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Zusammenfassung 
Der Nierenproximale Tubulus spielt eine fundamentale homöostatische Rolle, indem er eine 
große Menge an Stoffen resorbiert, einschließlich Proteine mit niedrigem Molekulargewicht, 
Glucose, Phosphat, Wasser und Vitamine, die sonst im Urin verloren gehen würden. Diese 
Kapazität beruht auf einem sehr effizienten Transportsystem, das der Rezeptor-vermittelten 
Endozytose einschließt, die die Aufnahme von essentiellen Nährstoffen in den Epithelzellen, die 
den proximalen Tubulus auskleiden, sowie deren korrekte Verarbeitung entlang des 
endolysosomalen Wegs sicherstellt. Das endolysosomale Kompartiment ist auch entscheidend für 
den Abbau von beschädigten Organellen und intrazellulären Materialien durch Autophagie, ein 
hoch konservierter Qualitätskontrollsystem, das die Aufrechterhaltung der Zellen sicherstellt. 
Angeborene Erkrankungen der Multi-Liganden-Endozytose-Rezeptoren (z.B. Donnai-Barrow 
oder Imerslund-Gräsbeck-Syndrom) oder der endolysosomalen Signalwege (z.B. Dent-Krankheit 
oder nephropathische Cystinose) sind mit einer niedermolekularen Molekulargewicht Proteinurie 
und einem Verlust von verschiedener gelösten Stoffen über den Urin verbunden, was oft zu 
multisystemischen Komplikationen und zur Progression einer chronischen Niereninsuffizienz 
führt. 
Im Laufe der Jahre wurde ein großes Interesse hinsichtlich der mutmaßlichen Rolle des primären 
Ziliums in den proximalen Tubulus geweckt. Diese Organelle sticht aus den meisten 
Säugerzellen heraus und wurde ausführlich auf ihre Fähigkeit hin beschrieben, extrazelluläre 
Stimuli wie den luminalen Fluss zu transduzieren, wodurch ein zellulärer Eintritt von Calcium 
Ionen ausgelöst wird, der dann mehrere zelluläre Prozesse reguliert. Interessanterweise wurden 
spezialisierte Strukturen, angereichert mit Clathrin-beschichteten Grübchen, die für die 
Initiierung der Endozytose entscheidend sind, an der Basis des primären Ziliens identifiziert. 
Jüngste Studien, die in immortalisierten Nierenzellen durchgeführt wurden, zeigten eine 
spezifische Zunahme der endozytischen Aktivität bei der Flussschubspannungsstimulation des 
primären Ziliums, eine Wirkung, die durch chemische Entfernung der primären Zilien 
aufgehoben wurde. Auch deuten mehrere Indizien darauf hin, dass Patienten mit einer autosomal-
dominanten polyzystischen Nierenkrankung (ADPKD), einem Prototyp der Ziliopathie, eine 
proximale tubuläre Dysfunktion aufweisen. ADPKD ist die häufigste ererbte Nierenerkrankung 
die bis zu 1: 1000 Menschen betrifft. Diese Krankheit ist durch die bilaterale Entwicklung von 
Zysten gekennzeichnet, die allmählich das normale Parenchym ersetzen und schließlich zu einer 
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terminalen Nierenerkrankung führen. Bei Patienten wurde in einem frühen Stadium der 
Erkrankung im Urin eine abnormale Ausscheidung der Marker für Schäden des proximalen 
Tubulus darunter KIM-1, β2-Mikroglobulin und β-Hexosaminidase nachgewiesen. 
Zusammengefasst legen diese Daten eine fundamentale Rolle des primären Ziliums in der 
endozytischen Funktion der Epithelzellen des proximalen Tubulus nahe. 
In dieser Arbeit untersuchte ich die zugrunde liegenden Mechanismen, die proximale tubuläre 
Dysfunktionen und Ciliogenese miteinander verbinden, mit genetischen Modellen von 
Ziliopathien sowie Modellen endolysosomaler Störungen (Dent-Krankheit und nephropathische 
Cystinose). Die klinische Relevanz unserer Studien wurde in einer Kohorte von Patienten mit 
ADPKD untersucht. 
Bei vielen Störungen der endolysosomalen Signalwege, wie der Dent-Krankheit, fehlt es an 
kurativen Therapien und die derzeitigen Bemühungen konzentrieren sich auf die Linderung der 
Symptome und Komplikationen, verursacht durch die Entwicklung der chronischen 
Nierenerkrankung. Kürzlich wurde gezeigt, dass Knochenmark- und hämatopoetische 
Stammzelltransplantation bei der nephropathischen Cystinose von Vorteil sind, indem die 
Nierenfunktion erhalten und der Cystingehalt in den Zellen gesenkt wird. Diese Ergebnisse 
werfen die Frage auf, ob eine Knochenmarktransplantation die Funktionsstörungen der 
proximalen Tubuli bei einer reinen endosomalen Störung wie der Dent-Krankheit korrigieren 
könnte. Im zweiten Teil der Arbeit untersuchen wir, ob eine Knochenmarktransplantation in dem 
etablierten Clcn5-Knockout-Mausmodell der Dent-Krankheit von Nutzen ist. Wir untersuchten 
die assoziierten Mechanismen mit Hilfe eines In-vitro-Systems von Knochenmarks Zellen co-
kultiviert mit primären proximalen Tubulus Zellen der Maus. 
Die hier beschriebenen Studien identifizieren eine neue Rolle des primären Ziliums in der 
Endocytose-Funktion der proximalen Tubulus Epithelzellen und liefern zellbasierte 
Therapieansätze  zur Verbesserung der Nierenfunktion.  
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Summary 
The proximal tubule of the kidney plays a fundamental homeostatic role by reabsorbing large 
amount of solutes including low molecular weight proteins, glucose, phosphate, water and 
vitamins which would otherwise be lost in the urine. This capacity relies on a very efficient 
transport system including receptor-mediated endocytosis, which ensures the uptake of essential 
nutrients and solutes in the epithelial cells lining the proximal tubule as well as their correct 
processing along the endolysosomal pathway. The endolysosomal compartment is also crucial for 
the removal of damaged organelles and intracellular materials through autophagy, a highly 
conserved quality control system that sustains cellular maintenance. Congenital diseases affecting 
the multi-ligand endocytic receptors (e.g. Donnai-Barrow or Imerslund-Gräsbeck syndromes) or 
the endolysosomal pathway (e.g. Dent disease or nephropathic cystinosis) are associated with low 
molecular weight proteinuria and the loss of various solutes in urine, which often leads to multi-
systemic complications and progression to chronic kidney disease.   
Over the years, a lot of interest has been gained regarding the putative role of the primary cilium 
in the proximal tubule. This organelle protrudes from most mammalian cells and has been 
extensively characterized for its ability to transduce extracellular stimuli such as the luminal flow 
into a cellular entry of calcium ions which then regulates multiple cellular processes. 
Interestingly, specialized structures enriched in clathrin-coated pits, which are crucial to initiate 
endocytosis, have been identified at the base of the primary cilium. Recent studies performed in 
immortalized tubular cells demonstrated a specific increase of the endocytic activity upon flow 
shear stress stimulation of the primary cilium, an effect abrogated by chemical removal of the 
cilia. Also, several lines of evidence suggest that patients affected by autosomal dominant 
polycystic kidney disease (ADPKD), a prototype of ciliopathy, exhibit proximal tubular 
dysfunction. ADPKD is the most common inherited kidney disorder, affecting up to 1:1000 
people. This disease is characterized by the bilateral development of cysts, progressively 
replacing the normal parenchyma and ultimately leading to end-stage renal disease. Patients with 
ADPKD have been shown to display abnormal urinary excretion of proximal tubule damage 
markers including KIM-1, β2-microglobulin, β-hexosaminidase at an early stage of the disease. 
Taken together, these data suggest a fundamental role of the primary cilium in the endocytic 
function of the epithelial cells of the proximal tubule. 
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In this thesis, I investigated the underlying mechanisms linking proximal tubular dysfunction and 
ciliogenesis using genetic models of ciliopathies and models of endolysosomal disorders (Dent 
disease and nephropathic cystinosis). The clinical relevance of our studies was evaluated in a 
cohort of patients suffering from ADPKD. 
For many endolysosomal disorders such as Dent disease, there is a lack of curative therapies with 
current efforts focused on alleviating the symptoms and complications due to the development of 
chronic kidney disease. Recently, bone marrow and hematopoietic stem cell transplantation have 
been shown to be beneficial in nephropathic cystinosis by preserving the kidney function and 
lowering the cystine content in the cells. These results raised the question of whether bone 
marrow transplantation would correct manifestations of proximal tubule dysfunction in an 
endosomal disorder such as Dent disease. In the second part of the thesis, we evaluated the effect 
of bone marrow transplantation in the well-established Clcn5 knock-out mouse model of Dent 
disease. We investigated the associated mechanisms using a co-culture in vitro system of bone 
marrow derived cells and primary mouse proximal tubular cells. 
The studies described here identify a novel role of the primary cilium in the endocytosis function 
of proximal tubule cells and provide a proof-of-concept for cell-based therapies to improve 
proximal tubule dysfunction 
 
.
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List of abbreviations  
 
AC6  Adenylate cyclase 6  
ADPKD Autosomal polycystic kidney disease 
AVP2R Arginine vasopressin receptor 2 
BM  Bone marrow 
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CCV  Clathrin-coated vesicles 
CKD  Chronic kidney disease 
ClC-5  Chloride-proton exchanger 
DAV  Distal appendage vesicle 
ESRD  End stage renal disease 
GFR  Glomerular filtration rate 
GvHD  Graft versus host disease 
HLA  Human leukocyte antigen  
HSC  Hematopoietic stem cell 
IFT  Intraflagellar transport 
LDL  Low density lipoprotein 
LMWP Low molecular weight proteins 
LSD  Lysosomal storage diseases 
MDCK Madin Darby canine kidney  
mPTC  Mouse primary proximal tubule cell 
MT  Microtubules 
mTOR  Mammalian target of rapamycin 
NHE3  Sodium–hydrogen exchanger 3 
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PC  Polycystin 
PDE  Phosphodiesterase 
PKA  Protein kinase A 
PT  Proximal tubule 
RFS  Renal Fanconi syndrome 
RME  Receptor-mediated endocytosis 
rPTC  Rat primary proximal tubule cells 
SNARE Soluble N-ethylmaleimide-sensitive factor Attachment Protein receptorTZ  
  Transition zone 
ULK  UNC51-like kinase 
V-ATPase Vacuolar ATPase 
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I- Introduction 
1. Kidney proximal tubule 
The kidney plays a fundamental homeostatic role by controlling the body fluid composition and 
regulating essential parameters such as the blood pressure, intercellular pH and the electrolyte 
equilibrium. From the 180 liters of primary urine that are daily filtered by the kidney, only 1.5 L 
of final urine is excreted, almost entirely devoid of low molecular weight (LMW) proteins and 
essential solutes, demonstrating the impressive ability of this organ to concentrate urine and 
reabsorbing essential metabolites, thus tightly controlling various homeostatic processes. To 
ensure its function, the kidney is composed of one million functional units, the nephrons. The 
latter contain a filtration unit, the glomerulus, followed by a long tubule structured in different 
segments made of highly specialized epithelial cells (Fig. 1.1). The glomerulus forms a very 
complex filtration barrier defined by podocytes with foot processes surrounding the fenestrated 
glomerular capillaries and  separated by a filtration slit permeable to water, electrolytes and  
LMW proteins (Haraldsson, Nystrom et al. 2008). After passing through the glomerulus, the 
ultrafiltrate is then heavily modified along the nephron to form the final urine. One of the largest 
contributors to this process is the first segment of the kidney tubule, the proximal tubule (PT). 
 
 
 
 
 
 
 
 
 
Figure 1.1: Structure of the nephron, functional unit of the kidney (adapted from (Mimura and 
Nangaku 2010) 
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1.1. Proximal tubular epithelial cells 
1.1.1.  Structure and function 
The epithelial cells lining the PT are highly differentiated allowing an efficient directional 
transport of many molecules from the primary urine to the blood circulation. The apical side of 
these cells is covered with densely packed microvilli forming the apical brush border, which 
effectively increases the luminal surface area and facilitates the reabsorption process. 
Morphologically the proximal tubule is subdivided in the convoluted part composed of S1 and S2 
segments and the straight part with S3 segment. The PT cells of the convoluted segment are 
characterized by a more developed brush border compared to the cells lining the straight segment 
and by the presence of numerous mitochondria, which provide the energy required by the high 
transport activity (Fig. 1.2) (Jacobson and Kokko 1976). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 1.2: Ultrastructure of the proximal tubule (adapted from (Maunsbach 1966) 
 
Without a functional PT, a substantial amount of ions, glucose and many other filtered elements 
including amino acids would be lost in the urine resulting in serious clinical manifestations 
(Camargo, Bockenhauer et al. 2008). The reabsorption of many solutes is possible due to the 
asymmetry of transport systems operating in the apical and the basolateral membrane of PT cells. 
Indeed, various cotransporters are expressed at the apical membrane allowing the coupling of the 
S1/S2 S3 
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uptake of solutes such as glucose, amino acids and phosphate to the uptake of Na
+
. These 
transports are driven by the Na
+
 gradient generated by the Na
+
-K
+
-ATPase pump expressed at the 
basolateral membrane. The importance of this process can be illustrated by the pivotal role of PT 
cells in regulating plasmatic pH by secreting protons H
+
 via the electroneutral Na
+
/H
+
 exchanger 
NHE3 and the reclamation of the buffer HCO3
- 
in parallel (Amemiya, Loffing et al. 1995). 
1.2. Receptor-mediated endocytosis and vesicular trafficking 
Most LMW proteins filtered through the glomeruli are reabsorbed in PT cells through receptor-
mediated endocytosis (RME) (Fig 1.3). This process is extremely efficient since the normal urine 
is virtually devoid of proteins. During the RME, filtered proteins bind the multi-ligands receptors 
megalin and cubilin which trigger their internalization in clathrin-coated vesicles. These vesicles 
are delivered to the endosomes where an acidification process allows the separation between the 
receptor and its ligand. Subsequently the receptor is recycled to the plasma membrane whereas 
the ligands are delivered and processed in the lysosome. The different elements of RME will be 
described in the following sections 
1.2.1. Endocytic receptors megalin and cubilin 
A remarkable variety of ligands are filtered through the glomerulus including vitamins, essential 
hormones and LMW proteins with a molecular mass below 60 kDa. The reabsorption of these 
solutes requires a dynamic ligand binding ability of receptors expressed at the apical membrane 
of PT cells. Megalin, a 600 kDa transmembrane protein which belongs to the low density 
lipoprotein (LDL) receptor family, possess a large extracellular domain conferring its ability to 
binds multiple ligands (Raychowdhury, Niles et al. 1989). More specifically, the extracellular 
domain of megalin is composed of numerous complement-type repeats which are essential to 
ligand binding (Fass, Blacklow et al. 1997, Wolf, Dancea et al. 2007). The cytoplasmic tail of 
megalin contains two endocytic motifs, NPXY and NQNY, which are crucial for clathrin-coated 
vesicles formation by interacting with AP-2 and for receptors apical sorting respectively (Collins, 
McCoy et al. 2002, Takeda, Yamazaki et al. 2003). 
The main interacting partner of megalin is cubilin, a 460 kDa protein that do not contain a 
transmembrane or an intracellular segment. 27 CUB (complement C1r/C1s, Uegf (epidermal 
growth factor-related sea urchin protein) domains have been identified in this protein, further 
14 
  
Megalin 
Cubilin 
AMN 
N-terminus 
C-terminus 
C-terminus 
increasing the ligand binding ability of the complex made by megalin and cubilin (Kristiansen, 
Kozyraki et al. 1999, Yammani, Seetharam et al. 2001). The correct trafficking of cubilin depend 
on amnionless, a 50 kDa transmembrane protein which includes two endocytic motifs in the 
cytoplasmic tail. Mutations in LRP2 (megalin), CUBN (cubilin) and AMN (amnionless) have 
been shown to impair endocytic activity resulting in several disorders such as Imerslund-
Gräsbeck or Donnai–Barrow syndrome (He, Madsen et al. 2005).  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 1.3: Schematic representation of receptor-mediated endocytosis (adapted from (Christensen, 
Birn et al. 2012)  
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1.2.2. Endosomes 
Upon internalization, the clathrin-coated vesicles containing the complexes ligand-receptor fuses 
with the endosomes. This process is determined by the interaction of complementary 
transmembrane proteins (v-SNARE and t-SNARE) and by Rab GTP-binding proteins (Wilson, 
Wilcox et al. 1989, Somsel Rodman and Wandinger-Ness 2000). The dissociation of the ligand-
receptor complexes occurs in the endosomes and is facilitated by a progressive acidification 
along the endocytic pathway, mainly driven by the influx of protons ions H
+
 mediated by the 
vacuolar-ATPase (V-ATPase) (Herak-Kramberger, Brown et al. 1998, Brown, Paunescu et al. 
2009). In absence of a compensating system, the constant proton influx would generate a 
transmembrane electrical potential ultimately resulting in V-ATPase inhibition. Indeed, to 
maintain electroneutrality, protons entry must be coupled with anion entry or cation exit. Several 
studies showed that chloride channels are instrumental in the dissipation of the transmembrane 
potential effectively defining Cl
-
 conductance as a major regulator of endosomal acidification 
(Scheel, Zdebik et al. 2005). In particular, the chloride-proton exchanger ClC-5, expressed at the 
endosomal membrane, establishes a countercurrent with a 2Cl
-
:1H
+
 stoichiometry which is 
fundamental to the endosome function. Disruption of ClC-5 is typically inducing a severe 
endocytic defect which will be discussed in the section 1.4. After dissociation of the receptor and 
its ligand, the former is recycled to the plasma membrane while the latter is targeted to lysosomes 
for degradation.  
 
 
 
 
 
 
 
Figure 1.4: Vesicular acidification along the endolysosomal pathway (adapted from Devuyst et al., 
2015)  
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1.2.3. Lysosomes 
The lysosomes, initially described by Christian de Duve in 1963, mediate the degradation and 
recycling of intracellular and extracellular material (Fig. 1.5) (De Duve 1963). Structurally, these 
organelle  are characterized by an acidic lumen containing numerous catabolic enzymes including 
hydrolases, sulphatases, lipases, nucleases, peptidases, glycosidases and phosphatases (Schroder, 
Wrocklage et al. 2010). The trafficking of these enzymes to the lysosomes, and their ability to be 
secreted and reabsorbed, is mediated by mannose-6-phosphate modifications in the Golgi 
apparatus and these properties have been used for enzymes replacement therapy for lysosomal 
storage diseases (LSD) (Neufeld 1980, Nielsen, Courtoy et al. 2007, Braulke and Bonifacino 
2009). The lysosomal acidification (pH ∼ 5) is generated by the V-ATPase with the contribution 
of other ion channels such as ClC-7 (Kasper, Planells-Cases et al. 2005, Marshansky and Futai 
2008). Of note, the lysosomal membrane is protected from the degradative enzymes by a thick 
glycocalyx lining its inner surface. Additionally membrane-associated RAB GTPases and 
SNARE proteins are located at the lysosomal membrane and mediate the fusion between 
lysosomes and different cellular compartments including late endosomes (Pryor, Mullock et al. 
2004, Rink, Ghigo et al. 2005). 
The main function of the lysosome is to degrade extracellular material, mostly originating 
from endocytosis, and cellular waste through the autophagic process which is essential for 
cellular homeostasis.  
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Figure 1.5: Main function of the lysosomes and their relationship with key cellular processes 
(adapted from (Settembre, Fraldi et al. 2013)) 
 
1.3. Autophagy 
Autophagy is a highly conserved mechanism resulting in the irreversible degradation of 
substrates from intracellular origin into essential components (e.g. aa) that are reused by the 
cells(Settembre, Fraldi et al. 2013). In basal conditions, autophagy is necessary to cellular 
maintenance by degrading long-lived proteins and organelles as well as the damaged cellular 
components. Different stimuli can induce an increase of autophagy activity such as nutrients 
deprivation (i.e. starvation), resulting in an increase of cellular energetic demands or an increase 
of reactive oxygen species (ROS) caused by oxidative stress (Kirkland, Adibhatla et al. 2002, 
Scherz-Shouval, Shvets et al. 2007). Dysfunctions of the autophagic process have been involved 
in various disease including neurodegenerative disorders and cancer (reviewed here (White 2015, 
Zare-Shahabadi, Masliah et al. 2015) highlighting the crucial role of this process in cellular 
homeostasis. 
The autophagic pathway can be classified in three types: chaperone-mediated autophagy, 
microautophagy and macroautophagy. The latter will be detailed in the current section and be 
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referred as autophagy. The initiation of autophagy begins with the engulfment of cytoplasmic 
portions by a double membrane structure called phagophore (Fig. 1.4). This mechanism is 
governed by the UNC51-like kinase (ULK) protein family which, in turn, activates the class III 
PI3K complex resulting in the formation of a pool of phosphatidylinositol specific to the 
phagophore compartment. Several proteins, namely ATG12-ATG5-ATG16, are recruited to the 
phagophore where the lipidation of microtubule-associated protein 1 light chain 3 (MAP1LC3 or 
LC3) with phosphatidylethanolamine is facilitated. LC3 lipidation results in the elongation of the 
phagophore forming an autophagosome. The autophagic vesicles subsequently fuse with 
endosomes creating amphisomes or directly with lysosomes forming autolysosomes where the 
degradation of cellular components takes place. Both autophagy and RME pathways share 
several cellular organelles including the lysosomes and disorders in either of these mechanisms 
severely impair PT function. 
 
 
 
 
 
 
 
 
 
 
 
Figure 1.6: Schematic description of macroautophagy in mammalian cells (adapted from  (Yang and 
Klionsky 2010) 
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1.4. Kidney proximal tubule dysfunction: Renal Fanconi syndrome 
The concept of defective proximal tubule reabsorption was first proposed by the Swiss 
pediatrician Guido Fanconi whose patients showed rickets and fever associated to glycosuria and 
albuminuria, hence the name renal Fanconi syndrome (RFS) (Fanconi 1931, de Toni 1933, 
Debré, Marie et al. 1934). This condition is characterized by the presence of polyuria, 
phosphaturia, glycosuria, aminoaciduria, LMW proteinuria resulting in several clinical 
manifestations including electrolytes imbalance, growth retardation, dehydration, muscle 
weakness, rickets and progressive renal failure. RFS can be caused by congenital disorders such 
as Dent disease and cystinosis or acquired in disorder such as light chain monoclonal 
gammopathy (Raggi, Luciani et al. 2014, Luciani, Sirac et al. 2016). 
1.4.1. Endosomal disorder: Dent disease 
Dent disease (MIM #300009, Xp11.22) is a rare X-linked renal tubulopathy caused by 
inactivating mutation in the CLCN5 gene which encode for the 2Cl
-
-H
+
 exchanger ClC-5 (Lloyd, 
Pearce et al. 1996, Scheel, Zdebik et al. 2005). Clinical features of this disease includes RFS 
associated with nephrolithiasis, nephrocalcinosis, LMWP and end stage renal disease (ESRD) 
between the third and the fifth decades of life in 30-80% of affected males (Scheinman 1998). 
These clinical manifestations highlight the importance of ClC-5 for the reabsorptive process in 
PT epithelial cells where this protein is markedly expressed. Studies in animal models harboring 
Clcn5 mutations showed that the inactivation of ClC-5 strongly impedes cellular trafficking with 
the loss of the apical expression of megalin and cubilin, endolysosomal disorders and impaired 
internalization of NaPi-IIa and NHE3 (Piwon, Gunther et al. 2000, Wang, Devuyst et al. 2000, 
Christensen, Devuyst et al. 2003). Although ClC-5 has been extensively described as a facilitator 
of endosomal acidification, it should be noted that the mechanisms involved in PT dysfunction 
are more complex. Indeed, Novarino and colleagues showed that a knock-in mouse model 
possessing a mutated ClC-5 converted in an uncoupled Cl
-
 conductor exhibited similar renal 
phenotype than the KO mouse model despite a normal endosomal acidification (Novarino, 
Weinert et al. 2010).  
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1.4.2. Lysosomal storage disorders: nephropathic cystinosis 
Lysosomes are essential to RME and dysfunctions of this organelle often result in a spectrum of 
diseases that are lysosomal storage disorders (LSD) often associated with manifestations of PT 
dysfunction. In fact, the leading hereditary cause of RFS in children is a genetic disease, 
nephropathic cystinosis, an autosomal recessive metabolic disorder caused by mutations in CTNS 
(MIM #219800, 17p13.2) which encode for a cystine-proton symporter, cystinosin (McDowell, 
Gahl et al. 1995, Gahl, Thoene et al. 2002). The loss of function of this transporter leads to the 
formation and accumulation of cystine crystals resulting in the impairment of the degradative 
ability of the lysosomes (Raggi, Luciani et al. 2014). The lysosomal impairment induces an 
increase of oxidative stress due to the defective autophagic clearance of damaged mitochondria 
ultimately resulting in the alteration of several intracellular pathways leading to PT defect (Festa, 
Chen et al. 2018). The patients with cystinosis rapidly develop RFS, which is invariably followed 
by the development of CKD and renal failure (Gahl, Thoene et al. 2002). 
Both Dent disease and cystinosis demonstrates that the integrity of the endolysosomal 
compartment is crucial for PT homeostasis. 
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2. Primary cilium 
The primary cilium is a highly conserved sensory organelle which protrudes from the surface of 
most mammalian cells. This structure was first characterized in the seminal studies of Sergei 
Sorokin (Sorokin 1968) who generated motile and non-motile cilia from fetal lung of rats. Motile 
cilia are present in specialized organs such as the Fallopian tubes and respiratory tract epithelium 
and differ from the non-motile cilia by their ability to generate movement (McGee, Johnson et al. 
1981, Lyons, Saridogan et al. 2006). Additionally, a single cell can possess several hundred 
motile cilia enabling the coordinated directional beating conferring fluid clearance properties for 
example in the lungs (Popatia, Haver et al. 2014).  Primary cilia have now extensively been 
described as key coordinators involved in many physiological processes such as left-right axis 
determination, development, chemosensation and mechanosensation. The following sections will 
focus on its morphological structure for a better understanding of its complex cellular function. 
2.1. Morphological structure 
2.1.1. Axoneme 
Structurally, the primary cilium is composed of nine peripheral microtubule (MT) doublets 
emanating from the basal body (Fig. 2.1) with a 9+0 arrangement. Compared to the motile cilia 
which possess a 9+2 MT arrangement, primary cilia lack the central pair of MTs as well as 
molecular motors such as dynein motor proteins required for ciliary movement. The tubulin 
present in the axoneme has been shown to be subjected to post-transcriptional modifications such 
as acetylation, glutamylation and glycation (O'Hagan, Silva et al. 2017, Wloga, Joachimiak et al. 
2017). These changes are essential for the stability and the function of the axoneme by regulating 
the interaction of the MT associated proteins namely kinesins or by ensuring the correct 
localization of some channels like polycystin-2 (PC-2). 
2.1.2. Basal body 
The basal body is a specialized structure present at the base of the primary cilium. The basal body 
originates from the centrosome and is required for the cilium formation. Indeed the centrosome, 
an organelle composed of two centrioles arranged in a cylindrical structure composed of nine 
triplets MT, plays an essential role in organizing the MTs network during cell division. At the 
exit of the mitotic cycle, vesicles originating from the Golgi apparatus as well as recycling 
endosomes, collective termed distal appendage vesicles (DAVs), are recruited at the distal 
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appendage of the mother centriole allowing its docking at the plasma membrane and initiating the 
centriole-to-basal body transition (Schmidt, Kuhns et al. 2012, Lu, Insinna et al. 2015). The basal 
body is anchored to the plasma membrane via specific structures that are the transition fibers and 
the distal appendages (Anderson 1972, Kobayashi and Dynlacht 2011). DAVs fuse in a ciliary 
vesicle triggering remodeling events which allow two of the three MT of the mother centriole to 
extend in the axoneme. 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 2.1: Overview of the primary cilium structure. CP: Clathrin-coated pit, TF: transition fibers, 
TZ: transition zone, MT: microtubules (Adapted from (Rohatgi and Snell 2010, Kobayashi and Dynlacht 
2011, Reiter, Blacque et al. 2012) 
2.1.3. Transition zone 
The transition zone (TZ) is a specialized ciliary subdomain present at the base of the cilium and 
act together with the transition fibers as a “ciliary gate” that regulates the trafficking of the 
proteins in and out of the axoneme (Chih, Liu et al. 2011, Garcia-Gonzalo, Corbit et al. 2011). 
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Morphologically the TZ is characterized by the presence of “Y-shaped” linkers which bounds the 
axoneme MTs to a specialized region of the ciliary membrane called ciliary necklace (Fig. 2.1) 
(Gilula and Satir 1972). A substantial number of proteins that either localizes to or are sorted 
through the TZ are associated with human diseases highlighting the crucial role of this 
subdomain for ciliary function. Indeed, mutations in gene BBS10 which encode for chaperonin-
like proteins that localizes to the TZ causes the Bardet-Biedl syndrome (BBS), a disorder 
characterized by polydactyly, cognitive impairment and renal anomalies (Marion, Stoetzel et al. 
2009). Similarly Joubert syndrome, a disorder of brain development, is caused by loss-of-
function of Tectonic1 (Tctn1) which impairs the ciliary gate (Garcia-Gonzalo, Corbit et al. 2011). 
2.1.4. Ciliary pocket 
The ciliary pocket is a region at the base of the cilium characterized by an invagination of the 
periciliary membrane which has gain interest over the recent years for its crucial role in vesicular 
trafficking (Rohatgi and Snell 2010, Pedersen, Mogensen et al. 2016). Indeed, morphological 
analyses by microscopy methods reveal that the structure of the ciliary pocket is maintained by 
stable and dynamic actin filaments. Additionally, clathrin-coated pits (CCPs) are present at the 
ciliary pocket with a higher density than the rest of the plasma membrane and functionally active 
as shown by their ability to form clathrin-coated vesicles (CCVs) (Molla-Herman, Ghossoub et 
al. 2010). The ciliary pocket plays a major role in regulating signal transduction by coordinating 
the localization and the internalization of receptors essential to ciliary signaling. In fact, 
transforming growth factor β (TGF-β) receptors have been shown to localize to the ciliary pocket 
upon TGF-β stimulation and increase the activation of downstream effectors like SMAD2/3 and 
ERK1/2, emphasizing the crucial importance of clathrin-dependent endocytosis for cilia signal 
transduction (Clement, Ajbro et al. 2013). 
2.2. Intraflagellar transport 
The primary cilia assembly and maintenance requires materials from different cellular organelles 
that cannot be synthesized in the cilia due to the lack of appropriate machinery. These elements 
are therefore provided by a mechanism called intraflagellar transport (IFT), a bidirectional 
transport system of multiprotein complexes relying on motor proteins (Ishikawa and Marshall 
2017, Prevo, Scholey et al. 2017). The IFT process is highly conserved in eukaryotes and was 
first described in the motile flagella of Chlamydomonas reinhardtii (Kozminski, Johnson et al. 
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1993) using microscopy methods. Since then, IFT has been extensively characterized and can be 
summarized in Fig. 2.2. To be functional, IFT requires IFT motor proteins and IFT complexes 
proteins. 
 
 
 
 
 
 
 
 
Figure 2.2: Intraflagellar transport machinery (Adapted from (Ishikawa and Marshall 2011) 
2.2.1. Ciliary motor proteins 
Essentially two motor proteins are involved in IFT, the heterotrimeric kinesin-2 responsible for 
the anterograde transport (from the ciliary base to the distal region of the axoneme) and the 
homodimeric dynein-2 ensuring the retrograde transport. Kinesin-2 consists of two motor 
subunits, KIF3A and KIF3B, and a non-motor subunit kinesin-associated protein. Kinesin-2 was 
originally isolated from sea urchin eggs (Cole, Chinn et al. 1993) and is vital for cilia assembly as 
KIF3B mutations were shown to severely impair cilia elongation and IFT in mice (Nonaka, 
Tanaka et al. 1998). Cytoplasmic dynein-2 is a complex multiprotein composed of different 
subunit: a heavy chain, a light intermediate chain, an intermediated chain and a light chain 
(Pazour, Wilkerson et al. 1998, Schafer, Haycraft et al. 2003). Dynein-2 is driving the retrograde 
transport and its contribution is more complex than kinesin-2. Indeed, it was shown that 
mutations targeting the light intermediate chain lead to a broad range of phenotype including a 
decrease of IFT dynein stability and a reduction of kinetic properties of retrograde IFT but not its 
complete loss (Reck, Schauer et al. 2016). 
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2.2.2. IFT complexes proteins 
Two large multimeric IFT protein complexes have been isolated with classic biochemical studies 
where conditional mutant of C. reinhardtii lose their cilia in a temperature-dependent manner 
(Piperno and Mead 1997, Cole, Diener et al. 1998). These complexes, IFT complex A and B, 
move along the cilia axoneme by interacting with the ciliary motor proteins, and exert distinct 
functions. IFT complex A, composed of at least six proteins, is mainly involved in the retrograde 
transport of protein from the cilium to the cell body but its role for cilia assembly seems limited 
(Absalon, Blisnick et al. 2008, Tsao and Gorovsky 2008, Iomini, Li et al. 2009). By contrast, IFT 
complex B, a much larger complex involving at least fourteen proteins, plays a significant role in 
cilia assembly and mutations in this complex have been shown to lead to shorter or abrogation of 
cilia (Pazour, Dickert et al. 2000, Haycraft, Schafer et al. 2003, Ou, Blacque et al. 2005, Follit, 
Tuft et al. 2006). The IFT complex proteins are enriched in protein – protein interaction domains 
conferring them unique properties for transporting cargo including ciliary tubulin, ciliary 
membrane proteins or signal transduction proteins ensuring the maintenance and the signaling 
role of the cilia (Avidor-Reiss, Maer et al. 2004, Craft, Harris et al. 2015). A particularly 
important IFT cargo is the BBSome which consists in a multimeric proteins complex involved in 
the removal of G-protein coupled receptors (GPCRs) and membrane-associated proteins from the 
cilia (Lechtreck, Johnson et al. 2009, Xu, Zhang et al. 2015).  
2.3. Regulation of ciliogenesis 
Considering that both cell division and primary cilia assembly rely on the centrioles, ciliogenesis 
usually occurs in quiescent cells at G1/G0 phase of cell cycle. Two main mechanisms have been 
described for cilia assembly, depending on cell type: ciliogenesis is either initiated intracellularly 
(in fibroblasts) or at the cell surface (in renal polarized epithelial cells). We will focus on the 
latter for the following sections. 
2.3.1. Assembly and disassembly of primary cilium 
The ciliogenesis begins when vesicles from the Golgi and recycling endosomes dock and fuse at 
the distal end of the mother centriole to form the ciliary vesicle (Sorokin 1962, Lu, Insinna et al. 
2015). This vesicular trafficking is tightly controlled by Rab GTPases among which Rab8a 
activation has been shown to regulate the elongation of the ciliary membrane (Yoshimura, Egerer 
et al. 2007). Subsequently, the mother centriole transitions to a basal body and docks to the 
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plasma membrane with the distal appendages (Tanos, Yang et al. 2013). These events involve the 
recruitment of different proteins such as Cep83, Cep89, Cep164, SCLT1 and FBF1 which 
facilitates the interaction between IFT proteins and distal appendages (Deane, Cole et al. 2001). 
Concomitantly, CP110, a strong inhibitor of ciliogenesis expressed at the basal body, is 
selectively degraded releasing the inhibition of the MT growth and the extension of the axoneme 
(Chen, Indjeian et al. 2002). 
The mechanisms involved in cilia disassembly are generally less well understood than their 
assembly counterpart. A biphasic model is currently proposed for this process. First, upon 
mitogenic stimulation, the kinase Aurora A is activated by the scaffolding protein Human 
enhancer of filamentation 1 (HEF1) and phosphorylate the histone deacetylase HDAC6, which 
promotes the destabilization of the axonemal MTs (Pugacheva, Jablonski et al. 2007). In a second 
phase, the activation of two members of the kinesin-13 family, Kif2a and Kif24, triggers the MTs 
depolymerization with Kif24 ensuring that this process is irreversible and that ciliogenesis cannot 
occurs during the S phase of cell cycle (Kim, Lee et al. 2015, Miyamoto, Hosoba et al. 2015). 
2.3.2. Autophagic control of ciliogenesis 
In recent years, autophagy has been established as a key regulator of ciliogenesis. The primary 
cilium is a very dynamic structure requiring a constant supply of proteins from the cell body: it 
has been shown that, in starvation-induced autophagy, several key anterograde components of the 
IFT machinery are routed through the basal body in vesicle containing autophagy-related proteins 
such as ATG16L1 which are essential to the autophagosomes formation (Fig. 2.3) (Pampliega, 
Orhon et al. 2013). However, the regulation of ciliary growth by autophagy is complex, 
considering that both proteins that promote and inhibit cilia elongation are degraded via the 
autophagic pathway depending on the type of stimuli (Pampliega, Orhon et al. 2013, Tang, Lin et 
al. 2013). Adding to the complexity, autophagy itself is regulating by different cellular 
mechanisms like mammalian target of rapamycin (mTOR) signaling. In fact, in nutrient-rich 
conditions, mTORC1 is recruited at the lysosomal membrane and inhibits autophagy. However, 
to prevent an excessive activation of mTORC1 signaling, a feedback loop system is established 
and involves the activation of the negative regulator GATOR1 mediated by Skp2 E3 ligase (Jin, 
Lee et al. 2015). The expression levels or activity of Skp2 E3 ligase has been demonstrated to 
partially explain the ciliary length in various cell types in a tissue. Taken together, these studies 
define autophagy as a crucial regulator of ciliogenesis with basal and induced autophagy exerting 
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different effects on ciliary growth in response to cellular demands and the fine tuning of this 
process is essential to cilia homeostasis. 
 
 
 
 
 
 
 
 
 
 
 
Figure 2.3: Molecular interaction between autophagy and ciliogenesis (adapted from 
(Pampliega and Cuervo 2016) 
 
2.4. Role of the primary cilium in kidney 
Primary cilia protrude from all the epithelial cells lining the kidney tubule, with the exception of 
the intercalated cells in the collecting ducts (Madsen, Clapp et al. 1988). One of the most studied 
functions of the cilia in the kidney tubule is the ability to transduce subtle changes in the laminar 
flow in cellular responses. The proposed model involves calcium entry in the cilia via specific 
channels, as shown in early studies using Madin Darby canine kidney (MDCK) cells where flow 
stimulation increases intracellular calcium (Praetorius and Spring 2001). In turn, this entry of 
calcium triggers the release of calcium from intracellular stores after activation of the ryanodine 
receptors (Jin, Mohieldin et al. 2014). Calcium ions are critical second messenger and the 
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increase of intracellular calcium regulates many intracellular processes including survival, 
differentiation or vitamin D synthesis (Cantiello 2004). 
More recently, a novel role of the primary cilium in controlling the endocytosis in epithelial 
cells of the proximal tubule has emerged. Indeed, considering that (1) the cilia possess 
specialized structure, namely, the ciliary pocket highly active in endocytosis initiation and (2) this 
organelle possesses mechanotransduction properties, the concept that the PT could adapt its 
activity depending on the glomerular filtration rate (GFR) has always been attractive. The first 
argument supporting this hypothesis came with evidence that albumin uptake was increased in an 
immortalized PT cell line upon flow stimuli in a microfluidic bioreactor (Ferrell, Ricci et al. 
2012). Subsequent studies showed that the increase of endocytic activity requires a functional 
primary cilium (Raghavan, Rbaibi et al. 2014). Nonetheless the precise intracellular pathways 
involved remain unclear with a putative contribution of calcium and mTOR signaling 
(Bhattacharyya, Jean-Alphonse et al. 2017, Long, Shipman et al. 2017). 
Finally, it should be noted that the primary cilium defines a signaling hub integrating many 
cellular pathways including Hedgehog, Wnt, PDGFRα and these mechanisms are important for 
kidney physiology despite not being kidney specific per se (Pala, Alomari et al. 2017). 
2.5. Ciliopathies 
A number of genetic defects targeting both motile and non-motile cilia have been associated with 
a spectrum of diseases collectively termed ciliopathies. These disorders often share overlapping 
manifestations but differ by distinct features due to the specific function of the gene in which the 
mutation occurs. The most common ciliopathies include nephronophthisis (NPHP), Joubert 
Syndrome (JS), Meckel-Gruber syndrome (MKS), Bardet-Biedl Syndrome (BBS), Senior Løken 
syndrome (SLS) and Leber Congenital amaurosis (LCA) (Waters and Beales 2011).  Among the 
different ciliopathies, we will focus on one of the most frequent inherited kidney disease, 
autosomal dominant polycystic kidney disease (ADPKD). 
2.5.1. Autosomal polycystic kidney disease 
ADPKD is one of the most common genetic causes of chronic kidney disease with a prevalence 
of up to 1:1000 live births (Willey, Blais et al. 2017). This disease is characterized by the 
development of numerous cysts which originate from all nephron segments resulting in the 
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enlargement of both kidneys and replacement of normal parenchyma (Wilson 2004). The 
glomerular filtration rate (GFR) remains preserved up to the age of 40 years in most patients 
because glomerular hyperfiltration in functioning nephrons compensates for the ongoing loss of 
renal tissue, until end-stage renal failure (ESRD) ensues in patients usually at 60 years old 
(Spithoven, Kramer et al. 2014). The total kidney volume (TKV) increases over time and is the 
strongest predictor of renal function decline in ADPKD (Grantham and Torres 2016). ADPKD 
diagnosis is based on imaging testing with renal ultrasound being the most common used method 
for cost and safety reason. Extrarenal manifestations can occur including cyst development in the 
liver or intracranial aneurysm.  
2.5.2. Polycystins 
ADPKD is associated with mutations in mainly two genes, PKD1 (MIM#601313, 16p13.3) 
which accounts for approximately 78% of affected patients and PKD2 (MIM#173910, 4q22) for 
13% (Audrezet, Cornec-Le Gall et al. 2012). About 10% of the patients do not present any PKD1 
or PKD2 mutations and these cases remains debated on whether another ADPKD locus exists.  
PKD1 encodes for polycystin-1 (PC1), a membrane protein of 460 kDa (about 4303 aa) 
containing a large N-terminal region (3074 aa), 11 transmembrane region (1032 aa) and an 
intracellular C-terminal region (197 aa) (Fig. 2.4). The extracellular region of PC1 contains a 
considerable amount of PKD repeat domains which precise function remain unclear and could be 
involved in protein-protein or protein-carbohydrate interaction. Additionally, this region possess 
a highly conserved G-protein-coupled site, the GPS domain, located just before the first 
transmembrane domain and mutations in this domain has been shown to improve survival in 
pkd1-null mice model (Yu, Hackmann et al. 2007) highlighting its functional importance for 
PC1. Finally the C-terminal region of PC1 allows the interaction with polycystin-2 (PC2) via the 
coiled coil domain. 
PC2, encoded by the PKD2 gene, is a smaller protein than PC1 (110 kDa) composed of a 
N-terminal cytoplasmic region, 6 transmembrane domains and a short C-terminal portion. PC2 
belongs to the transient receptor potential (TRP) channel family and calcium-binding motifs (EF-
hand) can be found in the C-terminal region supporting a role of PC2 in calcium signaling. PC2 is 
located at the base of the primary cilium as well as in the endoplasmic reticulum (ER) and forms 
a complex with PC1 which is involved in ADPKD cystogenesis. 
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Figure 2.4: Molecular structure of polycystin-1 and polycystin-2 (adapted from (Torres and Harris 
2009) 
2.5.3. Pathophysiology 
The cellular changes involved in ADPKD are summarized in Fig. 2.5. The precise function of the 
complex PC1-PC2 remains debated. The current model describes PC1 as a mechanoreceptor 
which induces calcium entry via PC2 in response to a flow stimulus (Nauli, Alenghat et al. 2003). 
This extracellular calcium would then activate PC2-ryanodine in the ER complex ultimately 
leading to the intracellular calcium release. Calcium controls several cell signaling pathways 
including the regulation of cyclic adenyl-monophosphate (cAMP) (Cooper, Mons et al. 1995). 
Indeed cAMP levels depends on the balance between the activity of the adenylate cyclase 6 
(AC6) favoring its synthesis and phosphodiesterase (PDE) 1 and 3 responsible for its degradation 
and low intracellular calcium have been associated to an increase of cAMP due to AC6 activation 
and PDE1/PDE3 inhibition (Wang, Ward et al. 2010). The increase of the second messenger 
cAMP leads to the activation of several proliferative pathways through the activation of the 
protein kinase A (PKA) and the associated downstream effectors such as extracellular signal 
regulated kinase (ERK), mTOR, c-AMP binding element response (CREB) and signal transducer 
and activator of transcription 3 (STAT3) (Yamaguchi, Nagao et al. 2003, Talbot, Song et al. 
2014). PKA is also involved in fluid secretion in the cyst via the activation of cystic fibrosis 
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transmembrane conductance regulator (CFTR) resulting in the excretion of chloride ions 
followed by sodium ions in the cyst lumen (Albaqumi, Srivastava et al. 2008). 
 AC6 is also regulated by the G-protein coupled receptor among which vasopressin 
receptor (AVP2R) expressed in the collecting duct and in the thick ascending limb plays a major 
role. Therefore several therapeutic strategies inhibiting AC6, thus reducing cAMP levels, have 
been developed and tolvaptan, an AVP2R inhibitor, has been shown particularly effective by 
slowing down the decline of GFR even in later stage ADPKD (Torres, Chapman et al. 2017). 
Recently the role of calcium signaling mediated by the primary cilia in ADPKD has been 
questioned for several reasons. Indeed, in a recent study, Clapham and colleagues developed a 
sophisticated model where genetically labelled calcium could be precisely monitored and they 
show that changes in ciliary calcium could not account for the overall cytoplasmic calcium 
variations (Delling, Indzhykulian et al. 2016). Additionally, it was shown that Ca
2+
 current can be 
mediated by polycystin-1L1 and polycystin-2L2 independently of the flow (DeCaen, Delling et 
al. 2013). These studies suggest that PC1/PC2 complex signaling involve partners yet to be 
discovered and the associated mechanisms could be independent from calcium.   
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Figure 2.5: Cellular pathways affected in polycystic kidney disease. AC-VI; adenylyl cyclase 6, CDK; 
cyclin-dependent kinase, ER; endoplasmic reticulum, MAPK; mitogen-activated protein kinase, mTOR; 
mammalian target of sirolimus, PC1; polycystin-1, PC2; polycystin-2, PDE; phosphodiesterase, PKA; 
protein kinase A, R; receptor, TSC; tuberous sclerosis proteins tuberin (TSC2) and hamartin (TSC1), 
V2R; vasopressin V2 receptor, V2RA; vasopressin V2 receptor antagonists (adapted from (Torres, Harris 
et al. 2007) 
 
2.5.4. Proximal tubule dysfunction in ADPKD 
Several lines of evidence indicate that ADPKD could be associated with specific defects targeting 
the epithelial cells lining the PT. Indeed, it is well established that the cysts originates from every 
nephron segment including PT (Devuyst, Burrow et al. 1996). Additionally, Pkd1 null mouse 
model exhibit polyhydroamnios and analyses of the amniotic fluid, a surrogate of the urine at this 
developmental stage, revealed increased level of solutes and proteins typically reabsorbed by PTs 
such as clara cell 16 (CC16) reflecting low molecular weight proteinuria (Ahrabi, Jouret et al. 
2010). This phenotype is associated with defects in the expression profile of the multi ligands 
receptors megalin and cubilin. A second argument supporting PT disorders in ADPKD context is 
the fact that patients shows specific urinary loss of vitamin D binding protein and transferrin in 
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absence of renal failure (GFR > 90 mL.min
-1
). Additionally, recent studies showed an association 
of proximal tubule markers including β2-microglobulin with GFR decline in patients with 
ADPKD (Messchendorp, Meijer et al. 2018). Finally, considering that PT homeostasis heavily 
relies on its transport ability and that the primary cilium has been recently described to play a 
significant role in endocytosis, one could hypothesize that there are mechanisms linking cilia 
dysfunction to PT disorders. 
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3. Bone marrow transplantation 
Bone marrow (BM) or hematopoietic stem cell transplantation (HSCT) is a curative therapy 
which has been shown beneficial for malignant and genetic diseases of the hematopoietic system 
such as leukemia, sickle cell disease or severe combined immunodeficiency (SCID). This 
procedure involves the injection of HSC from a compatible donor to the recipient after a 
myeloablative treatment either by radiation or by the use of chemotherapeutic agents to allow the 
engraftment of the injected HSC (Ljungman, Bregni et al. 2010). In the 1950s, bone marrow 
transplantation was demonstrated effective in animal experiments where mice and guinea-pigs 
showed higher survival after irradiation and subsequent transplantation from other animals 
(Lorenz, Congdon et al. 1952). In humans, Dr. E. Donnell Thomas pioneered stem cells 
transplantation in 1957 to treat a patient from leukemia and this work was followed in 1968 by 
the treatment and long-term survival of two patients suffering from SCID and the Wiskott-
Aldrich syndrome (Thomas, Lochte et al. 1957, Gatti, Meuwissen et al. 1968, De Koning, Van 
Bekkum et al. 1969). According to the worldwide network for blood and marrow transplantation 
(WBMT), over 50000 HSC transplants are carried out every year with about 90% success rate if a 
good combination donor recipient can be found. HSC are essential to this method and will be 
described in the following sections. 
3.1 Hematopoietic stem cells 
BM has been well established as the source of blood and immune cells throughout life. Seminal 
studies of Till and McCulloch identified the precise components of bone marrow allowing the 
renewal of blood cells thereby defining HSCs and their two unique core properties that are (1) the 
ability to self-renew and (2) to differentiate and generate a variety specialized cells (Till 1961). In 
fact, HSCs are the progenitor of all mature cell types of the mammalian blood system including 
erythrocytes, platelets, granulocytes, macrophages, dendritic cells, lymphocyte B/T cells and 
natural killer cells (Fig. 3.1). The main source of HSC is the bone marrow which can be isolated 
from the hipbone in humans for donor purposes. Alternatively, HSCs can also be found in 
peripheral blood but required the injection of granulocyte-colony stimulating factor (G-CSF), a 
glycoprotein that stimulates the production of granulocytes while hindering the mobilization of 
stem cells from bone marrow niches resulting in an increase of HSCs in the blood representing 
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then 1-2% of blood cells (Vij, Brown et al. 2000, Levesque, Hendy et al. 2003, Behfar, Faghihi-
Kashani et al. 2017). 
Mainly two types of HSCT are performed and will be described in the following sections: 
autologous and allogenic. 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3.1: Hematopoietic family tree describing the mature cells derived from HSCs CFU-s, colony-
forming unit-spleen; CMP, common myeloid progenitor; CLP, common lymphoid progenitor, MEP, 
megakaryocyte-erythroid progenitor; GMP, granulocyte-macrophage progenitor; BFU-E, burst-forming 
unit-erythroid; Meg, megakaryocyte; Eo, eosinophil; G, granulocyte; and M, macrophage. (adapted from 
(Metcalf 2007) 
3.1.1 Autologous hematopoietic stem cell transplantation 
Autologous HSCT consists in using the patient’s stem cell after removal of the malignancy to 
reconstitute the immune system. This therapeutic approach is used for certain leukemia and 
multiple myeloma and presents the advantage of a decreased risk of infection and graft versus 
host disease (GvHD). Recently the spectrum of diseases for which autologous HSCT is applied 
has also been expanded to autoimmune diseases like multiple sclerosis, systemic lupus, 
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rheumatoid arthritis and Crohn’s disease (Snowden, Passweg et al. 2004, Passweg and Tyndall 
2007, Mancardi, Sormani et al. 2017).  However, patient subjected to autologous HSCT present 
increased risk of de novo autoimmunity during re-emerging lymphopoiesis and also a potential 
increased frequency of secondary malignancies showing the need of additional prospective long-
term follow-up studies to assess the risk of developing complications after autologous HSCT 
(Daikeler, Tichelli et al. 2012). 
3.1.2 Allogenic hematopoietic stem cell transplantation 
Allogenic transplant is performed for a wider range of hematological diseases using HSCs from a 
human leukocyte antigen (HLA) matched donor who is either a relative or a person found in a 
donor bank. HLA are highly polymorphic genes that encode for the major histocompatibility 
(MHC) complexes expressed at the cellular surface and are crucial for the success of the 
engraftment as mismatches in MHC are associated with an increase of graft rejection and GvHD 
(Imus, Blackford et al. 2017, William, Wang et al. 2017). Allogenic HSCT is mainly used as a 
curative therapy for malignancies as the donor HSCs are able to reconstitute the recipient 
immune system which then generate T cells targeting the malignant cells by a mechanisms 
termed graft versus tumor (GvT). Compared to the autologous HSCs, allogenic stem cells do not 
require a conditioning protocol and thus are obtained more easily. One major concern of this 
procedure is that the risk of complications including graft rejection and GvHD is much higher as 
the donor T cells can target and damage the host tissues leading to the need of 
immunosuppressive treatment for most patients. 
3.2 Hematopoietic stem cell transplantation in kidney diseases 
The effectiveness of HSCT in non-hematopoietic diseases has long been debated. Despite these 
controversies, several mechanisms have been proposed to explain tissue repair including cell 
replacement, cell fusion and paracrine interactions (Wang, Willenbring et al. 2003, Ratajczak, 
Kucia et al. 2012, Ogawa, LaRue et al. 2013). Indeed it was suggested that HSC plasticity could 
be higher than expected and adipocytes, chondrocyte and fibroblasts were shown to exhibit 
markers of HSC origin leading to the hypothesis that cells HSC could fuse and/or replace 
differentiated cells other than blood and immune cells. (Lang, Ebihara et al. 2006, Sera, LaRue et 
al. 2009, Mehrotra, Williams et al. 2013). HSCT can be investigated using the methods 
summarized in Fig.3.2. Numerous studies have reported that BM and HSCT could be effective in 
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lysosomal storage diseases including leukodystrophy and Hurler syndrome (Krivit, Aubourg et 
al. 1999). More recently, Cherqui and colleagues elegantly showed in Ctns deficient mice that 
HSCT provided long-term renal protection by alleviating the proteinuria due to PT defects 
(Harrison, Yeagy et al. 2013). In a subsequent study, the mechanisms involved were refined 
showing that BM derived cells were engrafted in a stable manner and they exchanges functional 
protein and genetic materials by specialized structure called tunneling nanotubes (Naphade, 
Sharma et al. 2015). The nanotubes allow the transfer of vesicles containing material (RNA and 
protein) between the BM transplanted cell and the kidney cells. Therefore, combining 
fluorescently labelled proteins and live cell imaging techniques, Cherqui and colleagues showed 
that functional lysosomes were transferred from the BM cells to the kidney cells therefore 
improving the kidney function by decreasing the amount of cystine (Naphade, Sharma et al. 
2015). These seminal studies evidenced that HSCT can restore a functional transmembrane 
protein expressed in an intracellular compartment and raise the question of the effectiveness of 
HSCT in other type of endolysosomal disorders in the kidney. 
 
 
 
 
 
 
 
 
 
 
 
Figure 3.2: Principle of hematopoietic stem cell transplantation experiment (adapted from Dr. 
Miyoshi, RIKEN, BioResource Research Center)  
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The crucial role played by the PT in homeostasis relies on active transport systems that include 
receptor-mediated endocytosis. The latter drives the reabsorption of essential nutrients that are 
ultrafiltered, preventing their loss in the urine and ensuring that they are correctly processed 
along the endolysosomal pathway. Additionally, the endolysosomal system is essential for the 
degradation of intracellular materials and defective organelles through autophagy. In turn, 
dysfunctions in the endolysosomal system (e.g. Dent disease, cystinosis) are associated with 
urinary loss of solutes and LMW proteins, together with defective autophagy and accumulation 
of intracellular substrates including deficient mitochondria, with further consequences on the 
epithelial phenotype (Festa, Chen et al. 2018). Studies on the regulation of receptor-mediated 
endocytosis in the kidney have been largely focused on the deficiency or the trafficking of the 
receptors involved in this process (Nielsen, Christensen et al. 2016, De Matteis, Staiano et al. 
2017). 
A growing body of evidence shows that the primary cilium could regulate the endocytosis 
activity of the epithelial cells lining the PT. A specialized structure present at the ciliary base, the 
ciliary pocket, is enriched in clathrin-coated pits and is a very active site of clathrin-coated 
vesicles formation - the first step in receptor-mediated endocytosis (Molla-Herman, Ghossoub et 
al. 2010). Moreover recent studies evidenced a specific increase of endocytic activity upon 
mechanical stimulation of the primary cilium, an effect that is abrogated upon removal of the 
primary cilium (Raghavan, Rbaibi et al. 2014, Long, Shipman et al. 2017). On the other hand, 
autophagy, which depends on lysosomal function and also plays a preeminent role in PT 
function, has also been shown to be a major regulator of ciliogenesis (Pampliega, Orhon et al. 
2013, Tang, Lin et al. 2013). Finally, patients suffering from ADPKD, a prototype of ciliopathy, 
have been shown to display an abnormal urinary excretion of PT damage markers including 
KIM-1, β2-microglobulin, β-hexosaminidase at an early stage of the disease. Taken together, 
these data suggest a possible link between ADPKD, taken as a paradigm of ciliopathy, and 
defective endocytosis in the cells lining the kidney PT. The first aim of this thesis is to 
substantiate the evidence for PT dysfunction in ADPKD and to investigate the mechanisms 
linking PT dysfunction and ciliogenesis using congenital and inducible models of cystic 
kidney and endolysosomal disorders. 
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Few therapeutic solutions are available to target congenital disorders of the 
endolysosomal pathway, such as Dent disease, which is usually complicated by generalized PT 
dysfunction. The current efforts focus mostly on the prevention of complications due to the 
massive loss of solutes in the urine, of the development of CKD. Recently bone marrow (BM) 
and hematopoietic stem cells (HSC) transplantation have been shown to efficiently preserve 
kidney function in nephropathic cystinosis, a lysosomal storage disorder which the most frequent 
cause of renal Fanconi syndrome in children. The mechanisms of the protective effect of BM 
transplantation without indication of target tissue differentiation and replacement of damaged PT 
epithelial cells remain elusive. These studies also raised the issue of whether BMT would be 
beneficial for a pure endolysosomal disorder such as Dent disease. The second aim of the thesis 
is to assess whether bone marrow transplantation can preserve kidney function in the Clcn5 
KO mouse model of Dent disease and to study the potential mechanisms involved using a 
co-culture system of BM derived cells and primary mouse proximal tubular cells. 
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ABSTRACT  
The epithelial cells lining the proximal tubules (PT) of the kidney reabsorb large amounts of 
filtered solutes owing to a particularly efficient receptor–mediated endocytosis and 
endolysosomal pathway. A growing number of evidence suggests that receptor–mediated 
endocytosis could be regulated by the primary cilium and that ciliopathies could lead to PT 
dysfunction. The mechanisms underlying these associations remain poorly understood. Here we 
demonstrate, by combining in vitro and in vivo approaches, that anomalies in primary cilia are 
causing an epithelial phenotype switch, with proliferation and apical dedifferentiation leading to 
defective receptor–mediated endocytosis and PT dysfunction. These cellular abnormalities are 
linked to defective lysosome/autophagy–mediated elimination of intracellular flagellar protein 20 
(IFT20), which is required for cilia function and growth. Restoring cilia length, induced by IFT20 
depletion, rescues receptor–mediated endocytosis and PT epithelial function in a rat model of 
human ciliopathy. Conversely, IFT20 accumulation, which is caused by dysfunctional 
endolysosomal pathways, sustains cilia growth and PT dysfunction in acquired and congenital 
kidney disorders. These results evidence a functional interplay between ciliogenesis, receptor–
mediated endocytosis and autophagy–lysosome degradation pathways, so that impaired ciliary 
homeostasis is a common pathway underlying PT dysfunction in various kidney diseases.   
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INTRODUCTION 
The existence of an effective communication between the external environment and the 
endomembrane system is a fundamental property of epithelial cells. Such interplay between the 
lumen and the apical membrane domain is crucial in cells lining the intestine and the kidney, 
which absorb large quantities of essential nutrients through specialized transport processes. The 
kidney PT cells represent a paradigm for these properties, as they continuously recycle receptors 
and transporters at the apical membrane, ensuring the recovery of essential filtered substances 
that would otherwise be lost in the urine. These substances include low-molecular–weight 
(LMW) proteins that interact with multi–ligand receptors, megalin and cubilin, followed by 
internalization and subsequent delivery to endosomes and further to lysosomes for processing. 
This uptake accounts for ~80% of the total metabolic clearance of small proteins and peptides, 
playing an important role in preserving body homeostasis (Christensen & Birn, 2002). Congenital 
diseases targeting multi–ligand receptors (e.g. Donnai–Barrow or Imerslund–Gräsbeck 
syndromes) or the endolysosomal pathway (e.g. Dent disease or cystinosis) lead to massive 
urinary losses of solutes and LMW proteins, often complicated by multi-systemic complications 
and progression to end–stage renal disease (Devuyst & Luciani, 2015).  
Most mammalian cells have a primary cilium, a microtubule–formed organelle that 
protrudes toward the lumen and transduces signals (Malicki & Johnson, 2017). An interesting 
characteristic of the cilium is its ability to adjust morphology in response to environmental 
conditions. Indeed, cilia appear to act as a self–adjusting antenna, and modify their size and shape 
depending on the strength of the signal that they detect (Reiter & Leroux, 2017). By functioning 
as a signaling hub that senses different stimuli, primary cilia might regulate the specialized 
function of epithelial cells that line proximal tubule of the kidney. As a result, flow–induced 
ciliary Ca
2+
 and signaling might promote endocytic clearance of low–molecular weight (LMW) 
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proteins and other ligands from the glomerular filtrate via remote activation of LRP2 located at 
the base of microvilli (Raghavan et al, 2014). Interestingly, recent studies reported that Lowe 
syndrome protein OCRL1–a congenital disorder resulting in defective receptor–mediated 
endocytosis and PT dysfunction– might control the vesicular trafficking of ciliary proteins and 
signaling molecules (Coon et al, 2012; De Matteis et al, 2017) , ensuring the maintenance of 
primary cilia formation and composition. As such, defective primary cilia formation has been 
detected in kidney cells and zebrafish depleted of OCRL1 (Luo et al, 2012; Oltrabella et al, 
2015), highlighting potential interactions between primary cilium formation, receptor–mediated 
endocytosis and transport properties in PT epithelial cells.   
The formation and maintenance of the primary cilium depends on the continuous 
trafficking of structural, regulatory and signaling molecules in and out of the ciliary axoneme 
mediated by the intraflagellar transport (IFT) system. This vesicular trafficking is interconnected 
with autophagy, a pathway for degradation of cellular components in lysosomes (Settembre et al, 
2013). By removing specific ciliary proteins (e.g. IFT20), the autophagy–mediated degradation 
system – a homeostatic process particularly active in specialized epithelial cells– regulates 
primary cilia formation and biogenesis (Pampliega & Cuervo, 2016; Pampliega et al, 2013). 
Nonetheless, signaling ciliary proteins exit the cilium near the basal body, where regulatory 
autophagy–related proteins required for the autophagosome formation are located, suggesting that 
primary cilia signaling might safeguard cell homeostasis through the regulation of autophagy 
(Kaliszewski et al, 2015). This homeostatic process is particularly active in kidney cells, whose 
high reabsorptive transport activity requires an efficient autophagy-mediated clearance system to 
protect against acute tubular injury (Kimura et al, 2011). 
The regulation of apical endocytosis and the interplay between the primary cilia, the 
endolysosomal function and autophagy in particular are gaining attention due to their biological 
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relevance for tissue homeostasis and the pathogenic mechanisms of ciliopathies. Challenges in 
deciphering these interactions reflect experimental issues to modulate primary cilium functions 
and differences in epithelial phenotype and apical differentiation (Pampliega & Cuervo, 2016; 
Raghavan & Weisz, 2016). 
In the present study, we use the kidney proximal tubule as paradigm of epithelial 
differentiation to demonstrate a functional cross–talk between primary cilium, autophagy–
lysosome degradation system and endocytosis within specialized epithelial cells. Taking 
advantage of rat (Cy/+) and mouse (Pkd1) models of human ciliopathies (autosomal dominant 
polycystic kidney disease, ADPKD), in combination with in vitro studies on primary cultured 
kidney PT cells, we show that ciliary alterations are associated with a severe, specific defect in 
receptor-mediated endocytosis, reflecting a phenotype switch associating abnormal proliferation 
and dedifferentiation. Mechanistically, these cellular abnormalities are linked to defective 
lysosome/autophagy–mediated elimination of IFT20, which is required for cilia growth. 
Deregulated ciliary autophagy was also observed in other disease models that affect defective 
receptor–mediated endocytosis (e.g. Dent disease) and endolysosomal pathway (e.g. cystinosis 
and light chain disease), resulting in apical dedifferentiation and epithelial dysfunction, and in 
patients with ADPKD. These results indicate that impaired cilia/lysosome–autophagy interplay is 
a common pathway underlying PT dysfunction in various kidney diseases.   
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RESULTS 
Defective receptor-mediated endocytosis in HAN:SPRD Cy/+ rats  
We first investigated parameters of endocytic uptake in the Han:SPRD Cy/+ rats, an established 
model of ciliopathy characterized by the development of PT cysts with a slow progression of 
chronic kidney disease (Schafer et al, 1994). Cy/+ rats showed a marked increase in the urinary 
excretion of the LMW proteins transferrin, vitamin D binding protein (VDBP) and Clara cell 
protein of 16 kDa (CC16) from 5 weeks of age (Fig. 1A, B) when compared to their control 
littermates. The LMW proteinuria in Cy/+ rats was observed in absence of renal failure, as shown 
by the unchanged values of blood urea nitrogen (BUN) and serum creatinine (Table 1, Supp Fig. 
1A). Consistent with the pivotal role of receptor–mediated endocytosis in handling essential 
nutrients, Cy/+ rats displayed decreased expression of endocytic receptor megalin (Fig. 1C-D) 
contrasting the abnormal proliferation of PT cells as evidenced by a major increase in KI67 and 
PCNA (Fig. 1C-E). The defective megalin expression is likely due to post-transcriptional events 
since no significant changes were observed at the mRNA level (Suppl. Fig.1C).  
To substantiate the changes observed in vivo and confirm the defective epithelial phenotype in PT 
cells, we developed a primary culture system from micro-dissected PT segments from 
HAN:SPRD rat kidneys (rPTC), using well-established protocols (Terryn et al, 2007) (Luciani et 
al, 2016). The purity of the rPTC culture was verified by enrichment in specific segmental 
markers such as AQP1, NaPi-IIa and megalin and exclusion of distal tubule markers (Fig. 1F, 
Suppl. Fig. 2A). When grown to confluence, rPTCs showed a typical endocytic activity, as 
quantified by the uptake of fluorescent–tagged albumin (Al488-BSA), with a dose–dependent 
saturation and inhibition by Dynasore (80 μM, 30 min pre-treatment) (Suppl. Fig. 2B).  
The endocytosis activity of rPTCs derived from 5 week– old Cy/+ kidneys showed a 70%-
reduction of Al488-BSA uptake compared to the rPTCs derived from control littermates (Fig. 
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1E). The defect affected specifically receptor-mediated endocytosis, as the uptake of the fluid-
phase tracer alexa488-dextran was unaffected (Fig. 1E). The defective receptor–mediated 
endocytosis was reflected by the decrease in the protein levels of megalin in Cy/+ derived rPTCs 
compared to control rPTCs, increased expression of proliferation markers including PCNA (Fig. 
1F). 
These data demonstrate defective receptor-mediated endocytosis and PT cell dysfunction in a rat 
model of ciliopathy.  
 
Defective ciliogenesis impairs megalin expression and endocytosis  
Considering previous evidence suggesting that PT endocytosis could be regulated by the primary 
cilium (Long et al, 2017; Raghavan et al, 2014), we investigated whether the endocytosis defect 
observed in Cy/+ rats was related to primary cilium dysfunction. We tested this hypothesis by 
experimentally measuring ciliary growth. We observed that the ciliary length was markedly 
increased in Cy/+ kidneys and their derived rPTCs when compared to their control littermates as 
scored by confocal microscopy analysis of acetylated (Ac)–tubulin. (Fig. 2A, B).   As primary 
cilia functions as fluid flow sensing organelle (Kolb et al, 2004; Raghavan et al, 2014),we 
therefore asked whether abnormal ciliary elongation  might affect the endocytosis rate in 
response to fluid flow induced shear stress in Cy/+ rPTCs. The cells were subjected to fluid flow 
stimuli by using an orbital shaker at 1 Hz (Fig. 2B, C) for increasing amounts of time, followed 
by an endocytosis assay (Al647-BSA uptake). After 4h of stimuli, +/+ derived rPTCs showed a 
significant increase of endocytosis activity compared to the controls (Fig. 2B) paralleled by an 
increased expression of megalin (Fig. 2C). In contrast, fluid flow–stimulated–Cy/+ rPTCs 
experiencing long cilia showed decrease in receptor–mediated endocytosis and (Fig. 2B) in 
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megalin levels (Fig. 2C).  These data suggest that fine–tuned regulation of cilia growth maintains 
transport activity and function within kidney epithelial cells in response to mechanical cues. 
To further understand the ciliary defects in Cy/+ cells, we investigated regulators of ciliogenesis 
including intraflagellar transport (IFT) particles which are large multiprotein complexes essential 
for delivering ciliary proteins to the basal body and initiate cilium elongation (Follit et al, 2006). 
We studied two essential IFT proteins: IFT20 which shuttle between the Golgi complex and the 
basal body and IFT88 which localizes to the basal body and the axoneme of cilia. IFT20 
expression was significantly increased in Cy/+ derived rPTCs compared to their +/+ counterpart 
whereas IFT88 was unchanged (Fig. 2D). This abnormal expression occurred in absence of 
transcriptional changes for cilia assembly genes (Fig. 2E), implying defective turnover of ciliary 
proteins. 
In an attempt to mechanistically connect increased IFT20 with cilium growth and endocytosis 
defects, we we performed loss–of function approaches in primary renal tubular cells (PTCs) 
derived from Cy/+ rats. We then used an adenovirus–expressing shRNA-Ift20 to elicit Ift20 
deletion in primary renal tubular Cy/+ cells. 
The transduction reduced IFT20 expression in Cy/+ derived rPTCs to levels comparable to +/+ 
rPTCs (Fig. 2F), with normalization of cilia length (Fig. 2G), recovery of megalin expression 
(Fig. 2F) and improved endocytosis uptake (Fig. 2G). 
To further investigate the link between primary cilium and endocytosis, we treated mPTCs with 
cytochalasin D (100 nM, 12 h), an actin polymerization inhibitor which facilitates cilia 
elongation, followed by an endocytosis assay (Suppl. Fig. 3A-B). Treatment with cytochalasin D 
led to a significant increase in the primary cilia length, paralleled by a major decrease in Al647-
BSA uptake linked to an impairment of megalin expression while dextran uptake was unchanged 
(Suppl. Fig. 3A-B). Additionally, when cilia were chemically removed using ammonium sulfate 
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(Suppl. Fig. 3D), a similar decrease of the endocytosis activity was observed associated with a 
progressive loss of megalin (Suppl. Fig. 3E, F). 
Considering that the decrease of megalin expression in Cy/+ kidneys and derived rPTCs was 
observed in absence of transcriptional changes (Suppl. Fig. 1, 2) and that the primary cilium has 
been shown to regulate the proteasome activity (Gerhardt et al, 2015; Liu et al, 2014), we 
investigated whether the proteasomal degradation of megalin was affected by ciliary length. We 
first examined the ubiquitination rate of megalin by performing an immunoprecipitation of 
megalin from mPTCs treated with cytochalasin D for 12h and we observed a marked increase of 
megalin ubiquitination upon elongation of the cilia (Suppl. Fig 3C). Next, we treated Cy/+ 
derived rPTCs with MG-132, a proteasome inhibitor for 24 h and 48 h and we observed a 
recovery of megalin expression in Cy/+ rPTCs upon proteasome inhibition (Fig. 2H).  
Taken together, these results support a fundamental role of the primary cilia in regulating 
transport function in PT cells. 
 
Defective autophagy leads to an accumulation of the ciliary protein IFT20  
Recent studies have established that autophagy is a major regulatorciliogenesis by controlling the 
trafficking and the degradations of IFTs (Lee et al, 2016; Pampliega et al, 2013; Tang et al, 2013) 
. In view of the above findings, we hypothesized that the increased protein level of IFT20, which 
leads to cilia endocytosis dysfunctions in Cy/+ cells, might arise from alterations in autophagy 
pathway.  
The expression levels of the polyubiquitin-binding protein p62 and the microtubule-associated 
protein 1A/1B-light chain 3 (LC3), reflecting the number of autophagosomes, were significantly 
increased in Cy/+ kidneys compared to controls, with a major increase in immunofluorescence 
signal in PT segments (Fig. 3A-B), suggesting an impaired autophagic flux in Cy/+ kidneys.  
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To substantiate this hypothesis, we analyzed the autophagy flux in rPTCs by monitoring the 
conversion of LC3-I to the autophagosome-bound LC3-II and its subsequent degradation in 
presence or absence of nutrients. In nutrient-rich media, Cy/+ derived rPTCs exhibited an 
increase of LC3-II compared to +/+ rPTCs, which was not further increased in absence of 
nutrients (Fig. 3C). In presence of BafilomycinA1 (BfnA1), an inhibitor of the proton pump V-
ATPase blocking the late phase of autophagy, +/+ rPTCs cultured in nutrient-depleted medium 
showed as expected an increase of LC3-II and p62 compared to the nutrient-rich conditions, 
whereas LC3-II and p62 levels were unchanged in Cy/+ derived rPTCs (Fig. 3C). A similar 
profile was observed for IFT20 protein level (Fig. 3C) suggesting that the late-autophagy 
clearance is defective in Cy/+ derived cells. These findings were supported by electron 
microscopy analysis showing a marked increase of autophagic-like vacuoles containing 
undigested material in Cy/+ derived rPTCs (Fig. 3D).  
Furthermore we determined the intracellular localization of IFT20 in +/+ and Cy/+ derived rPTCs 
by transducing the cells with an adenovirus expressing LC3-GFP. In nutrient rich conditions, 
almost no colocalization was observed between LC3-GFP and IFT20 in +/+ rPTCs whereas a 
high number of LC3-GFP vesicles positive for IFT20 were detected in Cy/+ cells. In absence of 
nutrient and in presence of BfnA1, IFT20 accumulated in LC3-GFP vesicles in +/+ derived 
rPTCs while no change was observed for Cy/+ rPTCs suggesting that (i) IFT20 degradation was 
prevented in +/+ cells in presence of BfnA1 and (ii) the clearance of IFT20 is impaired in Cy/+ 
PT cells (Fig. 3E).  
Taken together, these data suggest that defective autophagic clearance is responsible for the 
accumulation of IFT20 in Cy/+ kidneys and cells. 
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Lysosomal dysfunction causes defective autophagic clearance and abnormal ciliogenesis 
. One mechanism by which the autophagic cargo clearance might be impeded is defective 
lysosomal degradation capacity (Festa et al, 2018). To investigate whether the defective 
autophagy clearance observed in Cy/+ kidneys is due to impaired lysosomal function, Cy/+ and 
+/+ rats were injected with Cy5 tagged lactoglobulin, a LMW protein typically reabsorbed and 
processed along the endolysosomal pathway in PT cells (Fig. 4A). At 15 min, the lactoglobulin 
uptake by PT cells was strongly reduced in Cy/+ compared to +/+ kidneys. At 120 min, the 
lactoglobulin signal was strongly reduced in +/+ kidneys compared to 15 min, indicative of 
efficient lysosomal degradation. In contrast, Cy/+ animals showed a significant increase of 
lactoglobulin vesicles at 120 min compared to 15 min, suggesting a profound defect in the 
lysosomal degradation of the tracer. The defective lysosomal activity in Cy/+ derived rPTCs was 
further evidenced by: (i) a striking decrease in the mature form of the lysosomal hydrolase 
cathepsin-D (CtsD) in presence or absence of BfnA1 (Fig. 4B); (ii) a 80% decrease in lysosomal 
degradation activity using Bodipy-FL PepstatinA (PepA), a fluorescent probe which specifically 
binds mature CtsD in acidic lysosomes (Fig. 4C); and (iii) a major reduction in the signal 
intensity following incubation of rPTCs with Magic-Red (MR), a substrate which fluoresces 
upon cleavage by the lysosomal cathepsin-B (Fig. 4C). It should be noted that Cy/+ animals 
presented a strong increase in the urinary excretion of CtsD, which is normally endocytosed 
through megalin (Nielsen et al, 2007), contributing to the lysosomal dysfunction in Cy/+ PT (data 
not shown). 
We next investigated whether established models of primary lysosomal dysfunction are also 
associated with a ciliary defect. We first used a model of acquired lysosomal dysfunction caused 
by the abnormal accumulation of specific  light chains ( LCs) in lysosomes (Luciani et al, 
2016). Mouse primary PT cells (mPTCs) cultured for 24 h with pathogenic LCs (κCH) showed 
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a significant increase of ciliary length compared to mPTCs cultured with control LCs (κCHm) 
that do not cause lysosomal dysfunction (Fig. 4D). The increased cilia length was associated with 
increased expression of IFT20 and p62 (Fig. 4E). Similar changes were observed in a Ctns 
knock-out mouse model of nephropathic cystinosis, a lysosomal storage disease that is 
characterized by a lysosomal accumulation of cystine leading to defective endocytosis (Raggi et 
al, 2014). The cilia length and IFT20 expression level were increased in PT cells of the Ctns
-/-
 
compared to wild-type kidneys, as shown by immunofluorescence staining (Fig. 4F).  
We assessed the primary cilia length in Clcn5
Y/-
 mouse model, a faithful model of Dent disease 
which exhibits a severe impairment of the endocytic activity and lysosomal processing 
(Christensen et al, 2003; Wang et al, 2000)) (Fig. 5B). The primary cilia length was significantly 
increased in AQP1 positive PTs kidney and mPTCs derived from Clcn5
Y/-
 (Fig. 5A-B). These 
changes were associated with a decreased expression of megalin and an increase of IFT20 as well 
as an impairment of the autophagic process shown by the increase of p62 levels (Fig. 5C). These 
data suggests that the integrity of endo-lysosomal compartment is fundamental to regulate the 
ciliogenesis.  
Taken together, these data demonstrate that congenital or acquired lysosomal dysfunction causing 
defective autophagic clearance of IFT20 leads to defective ciliogenesis. 
 
Autophagy regulates the primary cilia and the endocytosis activity 
To substantiate the link between autophagy, primary cilia and endocytosis, we investigated the 
effect of starvation-induced autophagy on these parameters in mPTCs (Fig. 6A-B). Serum 
starvation induced a progressive increase in the primary cilia length contrasting with a 
progressive decrease of albumin (Al647-BSA) uptake (Fig. 6A), paralleled by a decreased in 
megalin protein levels (Fig. 6B) culminating after 4 to 8h of starvation.  
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In a reverse experiment, we tested whether autophagy dysfunction alone was sufficient to disrupt 
the primary cilium morphology by using the Atg7
fl/fl
 inducible mouse model (Komatsu et al, 
2005). The increase of p62 and the near absence of LC3-II and ATG7 in Atg7
fl/fl
 derived mPTCs 
upon transduction with a Cre-expressing adenovirus confirmed a major autophagic dysfunction in 
this model (Fig. 6C). In absence of ATG7, mPTCs displayed significant increase of ciliary length 
associated to an increase of IFT20 and a decrease of albumin uptake (Fig. 6D).  
These data confirmed that autophagy regulates the primary cilium and endocytosis activity in PT 
cells.  
 
Ksp-Cre;Pkd1
del2–11,lox
  mouse model recapitulates defective autophagy and endocytosis 
To determine whether the defective autophagy and endocytosis observed in Han:SPRD Cy/+ rats 
is common to PKD and ciliopathies, we investigated the Ksp-Cre;Pkd1
del2–11,lox
  orthologous 
mouse model which is generated by kidney-specific tamoxifen-induced deletion of Pkd1 and a 
late disease onset when mice are injected at post-natal day 40 (Lantinga-van Leeuwen et al, 
2006). When analyzing urinary markers of PT function, 8-week old Pkd1
del2–11,lox
  exhibited a 
significantly increased excretion of the LMW proteins CC16 and transferrin – in absence of renal 
failure (Table 2, Fig. 7A-B).  
Investigation of the endocytic machinery in mPTCs derived from Pkd1
del2–11,lox
 kidneys showed a 
sizeable and specific reduction of megalin compared to controls, without general dysfunction of 
the endocytic machinery as shown by comparable levels of Rab5 and Rab7 (Fig. 7C), and an 
increased proliferation of PT cells as shown by PCNA immunostaining (Fig. 7D). The defective 
endocytosis was confirmed by a 60% reduction of the alexa488-albumin uptake in mPTCs 
derived from Pkd1
del2–11,lox
 kidneys compared to the controls (Fig. 7E). The defective endocytosis 
was paralleled by a significant increase of the primary cilia length (Fig. 7F) and of the IFT20 
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expression (Fig. 7D) in mPTCs derived from Pkd1
del2–11,lox
 kidneys. Autophagy process was 
impaired  as shown by the increase of p62 and LC3 in PT of Pkd1 deficient kidneys compared to 
the controls by immunostaining (Fig. 7G).  
 
Early manifestations of defective endocytosis and ciliogenesis in ADPKD patients  
Finally, we assessed the clinical relevance of our findings by measuring urinary markers of PT 
dysfunction in ADPKD patients with a normal kidney function, compared to healthy volunteers. 
16 ADPKD patients displayed an increase of microalbuminuria (Fig. 8A) as well as an increased 
urinary excretion of the LMW proteins transferrin and DBP (Fig. 8B). Studies on 5 kidney 
samples revealed that a marked increase in the ciliary length in the proximal tubule segments 
(AQP1-positive) in ADPKD compared to control kidneys (Fig. 8C) associated with a decrease of 
megalin expression (Fig. 8D). These data demonstrate that some ADPKD patients shows 
manifestations of PT dysfunction associated with morphological alteration of the primary cilium. 
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DISCUSSION  
The interplay between receptor-meditated endocytosis, endolysosomal processing and autophagy 
is critical for the capacity of PT cells to handle essential nutrients. A potential link between the 
primary cilium and flow-mediated regulation of endocytosis has been suggested by in vitro 
studies, but the underlying mechanisms as well as the relevance for ciliopathies or endolysosomal 
diseases remain unclear. Here, we used in vivo and in vitro approaches on various disease models 
to decipher the interplay between ciliogenesis, endocytosis, lysosomal function and autophagy in 
kidney PT cells taken as paradigm of specialized epithelial lineage. We show that genetic and 
pharmacologically-induced alterations of the primary cilium are associated with defective flow 
sensing and a selective defect in receptor-mediated endocytosis, causing lysosomal dysfunction, 
impaired autophagic degradation of IFT20, and further damage in the primary cilia and defect in 
endocytosis. This chain of events was recapitulated with models targeting endocytosis (Clcn5 KO 
mice, dynasore), lysosomal function (Ctns KO mice, light chains, bafilomycin A1) and 
autophagy (Atg7 KO, fasting). Defective receptor-mediated endocytosis and ciliogenesis was also 
verified in a cohort of patients with ADPKD.  
 The primary cilium has been extensively characterized for its ability to transduce external 
stimuli in intracellular responses (Pazour & Witman, 2003). In normal kidney tubules, primary 
cilia are thought to sense the luminal flow of urine and allow a rapid influx of calcium ions into 
the cells, which then controls multiple cellular processes (Nauli et al, 2003). Recent studies 
conducted on immortalized PT cells (OK, LLCPK) demonstrated that increased fluid shear stress 
(FSS) induces a rapid and sustained increase in both receptor-mediated (e.g. albumin uptake) and 
fluid-phase (e.g. dextran uptake) endocytosis, paralleled by an increase in intracellular Ca
2+
 
[Ca
2+
]i, and a release of extracellular ATP that required the presence of primary cilia (Raghavan 
et al, 2014). The involvement of primary cilia in the endocytic response to FSS in PT cells raised 
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the possibility that genetic defects in ciliogenesis could impair the regulation of apical 
endocytosis (Raghavan & Weisz, 2016). 
 Our investigations substantiate the defect in receptor-mediated endocytosis   in the 
Han:SPRD Cy/+ rat and in the Pkd1 inducible KO mouse, two models of autosomal dominant 
polycystic kidney disease (ADPKD), the most common inherited ciliopathy and by far the most 
common genetic cause of chronic kidney disease. The inbred Cy/+ rat strain resembles human 
ADPKD, with slow progression of cystic disease and renal failure. The kidney cysts are caused 
by missense mutations in ANKS6 (also named SamCystin) – a protein localized in PT cells, 
explaining why cysts predominantly originate from the PT in this model (Brown et al, 2005). 
Recessive mutations in ANKS6 have been identified in families with nephronophthisis, with 
ANKS6 playing a crucial role in an interacting module linking NEK8 to INVS and NPHP3 in the 
Inv compartment at the proximal part of the body of the cilium (Hoff et al, 2013; Nakajima et al, 
2018). The vast majority (about 85%) of individuals with ADPKD carry mutations in PKD1 
encoding polycystin-1 (Ong, 2017). Polycystin-1 is a membrane protein localized in the ciliary 
membrane, where it is involved in cell signalling (Pazour & Witman, 2003). The disruption of 
Pkd1 after post-natal day 12 in mouse results in a slow cystogenesis process, reflecting a state of 
differentiation and corresponding to the human disease (Piontek et al, 2007).  
Of note, the defect in receptor-mediated endocytosis is observed at an early stage of disease - 
before any renal failure in these models. 
The results were confirmed in ADPKD patients (PKD1 mutation) who exhibit a loss of several 
LMWPs typically reabsorbed by the PT, in the early stage of disease and with normal renal 
function (eGFR < 90 ml.min
-1
), together with increased primary cilia length on PT cells. 
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 The changes in primary cilia and receptor-mediated endocytosis observed in vivo were 
recapitulated in primary cultured PT cells obtained from the Han:SPRD rat (rPTC) and Pkd1 
mouse (mPTC) models. These cells, which keep their differentiation and polarized transport 
processes, provide a particularly well suited model to investigate receptor-mediated endocytosis 
of apical ligands and their lysosomal processing (Festa et al, 2018; Raggi et al, 2014; Terryn et al, 
2007). Our studies reveal that the primary ciliopathies induced a selective defect in RME 
(monitored by albumin uptake), observed both in static and flow conditions, and a consistent loss 
of megalin. Similar loss of megalin and decreased albumin uptake were observed upon exposure 
of mPTC to cytochalasin D which promotes cilia elongation and to NH4SO4 which deciliates 
mPTCs. The consistent loss of megalin, associated with increased cell proliferation, suggest an 
early loss of differentiation of the tubular cells - similar to what has been observed in 
endolysosomal disorders such as cystinosis (Festa et al, 2018) and light chain-associated 
tubulopathy (Luciani et al, 2016).  
 The robust increase in ciliary length associated with the endocytic defects in the 
Han:SPRD rat and Pkd1 mouse in vivo and in vitro was associated with a specific increase in the 
expression of IFT20, a critical component that regulates ciliogenesis through continuous and  
bidirectional intraflagellar trafficking (Follit et al, 2006). Functioning of the primary cilium has 
been recently connected to autophagy, a pathway for degradation of cellular components in 
lysosomes.  Autophagy regulates the length of the cilia by modulating the load of essential 
proteins required for ciliogenesis, a phenomenon that is molecularly different performed by basal 
autophagy or when autophagy is induced in response to various stressors (Pampliega & Cuervo, 
2016). Interestingly, basal autophagy–a homeostatic pathway which occurs in kidney epithelial 
cells under normal nutrient conditions– prevents ciliogenesis by sparing OFD1 (Tang et al, 2013) 
and digesting IFT20 (Pampliega et al, 2013), the latter being essential for both cilium formation 
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and length regulation. This “double lock” hints at the importance of proper cilia regulation for 
cell homeostasis and functions. In line with this model, our data indicate that an abnormal 
accumulation of IFT20 leads to increased ciliogenesis and primary cilia elongation in rat and 
mouse cell–based models and, notably, in kidney epithelial cells of patients with ADPKD. The 
correction of primary cilia length defects by loss–of–function interventions targeting IFT20 
rescue epithelial differentiation and reabsorptive capacity in Cy+ kidney epithelial cells, 
substantiating the essential role of primary cilia homeostasis in safeguarding epithelial phenotype 
in specialized cells.   
 As target–of–rapamycin complex1 (mTORC1) signaling has been associated with ciliary 
size and function, we reasoned that an upregulation of proteins that are critical for ciliogenesis 
and cilia elongation, such as intraflagellar proteins and tubulin, might be responsible for cilia 
elongation in response to mTORC1 activation (Yuan et al, 2012). However, the IFT20 
accumulation is still detectable in Cy+ cells under conditions in which mTOR is either silent or 
fully active, suggesting that the ciliary length defects are not  dependent on mTORC1 activation 
or inactivation. Combined the accumulation of ciliary protein IFT20 and the fact that basal 
autophagy maintains cilia length and homeostasis by removing IFT20, these findings prompted 
us to examine the potential involvement of autophagy in the dysregulation of ciliogenesis and 
primary cilia formation. Consistent with our hypothesis, we observed that genetic blockage of 
basal autophagy (e.g. Atg7 knockdown) results in accumulation of IFT20, leading to elongation 
of primary cilium and epithelial dedifferentiation - dysfunction as reflected by decreased 
endocytotic uptake capacity. These results demonstrate the importance of quality-control 
mechanism in maintaining primary cilia length and formation.  
 Similar to the changes observed in autophagy—deficient cells, there was a remarkable 
accumulation in Cy+ kidney epithelial cells of p62–and ubiquitin–forming aggregates, with 
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ciliary protein IFT20 accumulating within autophagosomes. The accumulation of the autophagy 
substrate p62, which is normally degraded within autolysosomes, suggests an abnormal 
autophagy flux in Cy+ and Pdk1 depleted cells.  Evidence supporting the failure to degrade 
autophagy cargoes in primary PT Ctns
-/-
 cells include: abnormally elevated numbers of mature 
autophagosomes under-normal growth conditions; failure to clear autophagic vesicles (AVs) 
formed after starvation-induced autophagy, mimicking BfnA1 action; inability of BfnA1 to 
further induce the LC3-II protein levels.  Altogether, these data indicate that the alterations of 
ANKS6 and PC1, causing ciliary length and endocytosis defects, delays the autophagy flux, 
leading to an accumulation of autophagosomes in vitro and in vivo. 
 The question remained how ANKS6 and PC1 impairment could impair autophagy flux 
and lead to defective removal of IFT20 and ciliary length defects. We postulated that defects in 
ANKS6 and PC1 may affect lysosome function either by controlling the delivery of newly 
synthesized lysosomal cathepsins from Golgi to the lysosome or by inhibiting the 
processing/maturation of cathepsins within endolysosome compartment. Our results support the 
latter hypothesis, evidencing an impairment of lysosome proteolysis (observed both in vitro and 
in vivo) as a result of defective cathepsin activation despite an efficient delivery of newly 
synthesized cathepsins from Golgi to lysosomes. Therefore, lack of autophagy completion, due to 
impaired lysosomal degradation capacity or through inactivation of essential genes, leads to 
defective clearance of ciliary proteins, leading to IFT20 accumulation which ultimately causes 
primary cilia length defects.  
 The conjugation of impaired autophagy and altered lysosomal degradative capacity is 
strikingly similar to the cellular changes resulting from the accumulation of monoclonal light 
chains (LCs) or cystine within endolysosomes of PT cells, causing a similar epithelial 
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dysfunction (Festa et al, 2018; Luciani et al, 2016). Furthermore, dysfunction of endosomal 
pathway that results from the loss–of–function of Clcn5, leads to defective autophagy–mediated 
removal of IFT20 in lysosomes, recapitulating IFT20 accumulation and cilia elongation in kidney 
epithelial cells from a mouse model of Dent disease– congenital disorder causing defective 
receptor–mediated endocytosis and PT dysfunction. These data suggest that dysfunctional 
endosomal—lysosomal pathways due to congenital (Dent disease or cystinosis) or acquired (light 
chain disease) disorders might have similar functional consequences on epithelial phenotype, 
emphasizing the role of primary cilia as a crucial signaling hub to ensure cellular function and 
homeostasis.  
These findings have a clinical relevance for biomarkers in early ADPKD. Cystogenesis in 
ADPKD primarily involves dedifferentiation of kidney tubular cells, with enhanced proliferation, 
abnormal fluid secretion and defective planar cell polarity, promoting cyst development and 
growth (Ong, 2017). This chain of events involves all tubular segments, including the proximal 
tubule (Devuyst et al, 1996; Terryn et al, 2011; Verani & Silva, 1988). Our findings substantiate 
evidence pointing to increased urinary excretion of PT marker damage including β2-
microglobulin and β-hexosaminidase in the early phase of ADPKD (Casal et al, 2005; Meijer et 
al, 2010; Swedenborg et al, 1981; (Messchendorp, Meijer et al. 2018). Furthermore, Pkd1-null 
embryos exhibit an abnormal expression of megalin in PT cells and an inappropriate loss of 
LMW proteins in the amniotic fluid (Ahrabi et al, 2010). Altogether, these data suggest a specific 
and early PT defect in ADPKD.  
In conclusion, our findings support a fundamental novel role of the cilia in the endocytic process 
These results open perspectives for autophagy-lysosomal targeted interventions to correct PT 
dysfunctions in PKD. 
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MATERIAL AND METHODS  
Patient. Human kidney biopsies and urinary samples were obtained from archived samples of 19 
patients with clinical diagnosis of ADPKD and a glomerular filtration rate (GFR) above 90 
ml.min
-1
. The use of the human samples was approved by the Ethical Review Board of the 
Université catholique de Louvain Medical School (Brussels, Belgium). 
Animals. The experiments were performed on several animal models: male Han:SPRD 
heterozygous Cy/+ rats (5-9 weeks-old) Ksp-Cre;Pkd1
del2–11,lox
  mouse (8 weeks-old), female 
Ctns
-/-
 mouse (20 weeks-old), male Clcn5
Y/-
 (8weeks-old), male Atg7
fl/fl
 mouse(8-12 weeks-old) 
and C57bl/6 mouse (8 weeks-old). Age and gender-matched littermates were used as controls.   
All procedures were performed in accordance with the National Institutes of Health guidelines for 
the care and use of laboratory animals and with the approval of the Committee of the University 
of Zürich (Zürich, Switzerland).  
Renal function parameters. The animals were trained once and kept in metabolic cages overnight. 
The urine was collected on ice and the diuresis was measured. After euthanasia, blood samples 
were obtained from the vena cava and collected in heparin coated tubes (Sarstedt, Nümbrecht, 
Germany). Urine and plasma parameters were analyzed using the UniCel® DxC 800 Synchron® 
Clinical system. Urinary LMWP were measured by western blot whereas Clara cell protein 
(CC16) concentrations were determined an enzyme-linked immunosorbent assay kit (Biomatik 
EKU03200, Wilmington, DE, USA) (Festa et al, 2018; Luciani et al, 2016). 
Histological studies. After euthanasia, the kidneys were rapidly excised, rinsed in 0.1M 
phosphate buffer saline (PBS) solution (Thermo Fischer Scientific, MA, USA), fixed in 4% 
paraformaldehyde in PBS for 6 h and embedded in paraffin at 58 C°. Paraffin blocks were 
sectioned into consecutive 5 μm-thick slices with a Leica RM2255 rotary microtome (Thermo 
Fisher Scientific) on Superfrost Plus glass slides (Thermo Fisher Scientific). The sections were 
subsequently deparaffinized with Xylene and rehydrated with a descending ethanol percentage. 
Antigen retrieval was performed using the heat-induced epitope retrieval methods by incubating 
the slides in sodium citrate buffer (1.8% 0.1 M citric acid, 8.2% 0.1 M sodium citrate, in 
distillated water, pH 6.0) at 95 C° for 30 min. The slides were subsequently processed for 
immunofluorescence staining and confocal microscopy. (Festa et al, 2018; Luciani et al, 2016)  
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Primary culture. After excision, the rat or mouse kidneys were dissected in a 4°C dissection 
solution (DS) (HBSS with in mmol/l: 10 glucose, 5 glycine, 1 alanine, 15 HEPES, pH 7.4 and 
osmolality 325 mosmol/kgH2O) which allow the separation in medullar and cortical fragments. 
The medullar fragments were discarded while the cortical pieces were subsequently incubated in 
a collagenase solution (DS with 0.1% (wt/vol) type-2 collagenase and 96 μg/ml soybean trypsin 
inhibitor) for 30 min at 37°C. After the incubation period, the supernatant was filtered using 250 
μm and 80 μm pore size nylon sieves. The proximal tubules (PTs) were then collected on the 80 
μm nylon sieve in 37°C DS and centrifuged 5 min at 300g. Finally the PTs were resuspended in 
the culture medium 1:1 DMEM/F12 without phenol red and supplemented with heat-inactivated 
FCS 1%, HEPES 15 mmol/l, L-glutamine 2 mmol/l, hydrocortisone 50 nmol/l, insulin 5 μg/ml, 
transferrin 5 μg/ml, selenium 50 nmol/l, sodium pyruvate 0.55 mmol/l, 100× nonessential amino 
acids 10 ml/l, penicillin 100 IU/ml and streptomycin 100 μg/ml buffered to pH 7.4 and osmolality 
of 325 mosmol/kgH2O and seeded on the appropriate support. (Festa et al, 2018; Luciani et al, 
2016) 
Endocytosis assay: The endocytic uptake was monitored in mPTCs cells following incubation for 
15 min at 37 °C with 100 μg ml−1 bovine serum albumin (BSA)–Alexa-Fluor-647 (A34785, 
Thermo Fisher Scientific) or with 100 μg ml−1 BSA–Alexa-Fluor-488 (A13100, Thermo Fisher 
Scientific) in complete HEPES-buffered Dulbecco’s modified Eagle’s medium. The cells were 
given an acid wash, fixed and processed for immunofluorescence analyses (Luciani et al, 2016). 
Adenovirus transduction in primary PT cells: For RNA interference studies, the adenovirus 
constructs include scrambled short hairpin or shRNAs encoding individually rat Ift20 or encoding 
mouse Atg7. For expression studies, adenovirus constructs include cytomegalovirus (Null) or 
particles individually carrying mouse GFP-tagged-Map1lc3b. The abovementioned adenovirus 
constructs were purchased from Vector Biolabs (University City Science Center, Philadelphia, 
USA). The primary mouse or rat PT cells were plated onto collagen-coated chamber slides or 24-
well or 6-well tissue culture plates. Adenovirus transduction was performed 24 h after plating 
when the cells reached ~ 70–80% confluence. The cells were subsequently incubated for 16 h at 
37 °C with culture medium containing the virus at the concentration (0.2125 × 109 PFU ml−1). 
The cells were afterwards challenged with fresh medium every 2 days, cultured for 5 days (unless 
otherwise specified), and collected for analyses. 
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Quantitative real-time PCR: Total RNA was extracted from mouse and rat kidney tissues using 
Aurum Total RNA Fatty and Fibrous Tissue Kit (Bio-Rad, Hercules, CA). DNAse I treatment 
was performed to eliminate genomic DNA contamination. Total RNA was extracted from 
primary cell cultures with RNAqueous kit (Applied Biosystems, Life Technologies). One 
microgram of RNA was used to perform the reverse transcriptase reaction with iScript cDNA 
Synthesis Kit (Bio-Rad). Changes in mRNA levels of the target genes were determined by 
relative reverse transcriptase-quantitative PCR with a CFX96 Real-Time PCR Detection System 
(Bio-Rad) using iQ SYBR Green Supermix (Bio-Rad). The analyses were performed in duplicate 
with 100 nM of both sense and anti-sense primers in a final volume of 20 µl using iQ SYBR 
Green Supermix (Bio-Rad). Specific primers were designed using Primer3. PCR conditions were 
95 °C for 3 min followed by 40 cycles of 15 s at 95 °C, 30 s at 60 °C. The PCR products were 
sequenced with the BigDye terminator kit (Perkin Elmer Applied Biosystems) using ABI3100 
capillary sequencer (Perkin Elmer Applied Biosystems). The efficiency of each set of primers 
was determined by dilution curves. The program geNorm version 3.4 was applied to characterize 
the expression stability of the candidate reference genes in kidneys and six reference genes were 
selected to calculate the normalization factor (Vandesompele et al, 2002). The relative changes in 
targeted genes over Gapdh mRNAs were calculated using the 2
−ΔΔCt
 formula. 
Lysosomal activity: The detection of lysosomal activity was performed in live rPTCs using 
Bodipy-FL-PepA (P12271, Thermo Fischer Scientific) or Magic Red-(RR)2 substrate (MR-CtsB; 
938, Immunochemistry Technologies) according to the manufacturer’s specifications. The cells 
were pulsed with 1 μM Bodipy-FL-Pepstatin A or with 1 μM Magic Red-(RR)2 in Live Cell 
Imaging (A14291DJ, Thermo Fischer Scientific) medium for 1 h at 37 °C followed by fixation 
and subsequently analyzed by confocal microscopy (Luciani et al, 2016). 
Human κLCs: Human LC genes were isolated and transfected in the hybridoma cell line SP2/0 as 
previously described (Luciani et al, 2016). Briefly the human LCs were produced by the SP2/0 
cell line, a B cell hybridoma lacking endogenous Ig and constitutively overexpressing human 
LCs from patients with biopsy-proven renal Fanconi syndrome (κCH). For control, a mutant 
version of κCH (κCHm) was generated with Ala30Ser which causes in a low aggregation 
rendering κCHm non-pathogenic. For the uptake of all human κLCs, primary mPTCs were plated 
in culture medium, briefly rinsed, and then cultured for 4h in serum-free, HEPES-buffered 
DMEM/F12. The cells were then incubated with 25µg/mL of human κLCs in serum-free, 
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HEPES-buffered DMEM/F12 for 60 min at 4°C and chased in κLCs-free, complete medium for 
the indicated times at 37°C, before being processed for western blotting or immunofluorescence 
analyses. Each incubation was dome using a different, non-pooled monoclonal κLC. 
Electron microscopy. Confluent rat proximal tubule cell monolayers were fixed with 2.5% 
glutaraldehyde in 0.1 M cacodylate buffer and embedded in LR-White resin (LADD Research 
Industries). The grids were viewed on a Philips CM100 transmission electron microscope at 
80 kV. Autophagic vacuoles were identified and categorized as autophagosomes or 
autophagolysosomes according to standard criteria (Klionsky et al, 2012). The term autophagic 
vacuole was used when the differentiation between autophagosome and autophagolysosomes was 
not possible. 
Immunofluorescence and Confocal Microscopy. Five-μm kidney sections were quenched with 50 
mM NH4Cl, blocked with 3% BSA in PBS Ca/Mg (D1283; Sigma-Aldrich) for 30 min and 
stained with primary antibodies diluted in blocking buffer overnight at 4°C. After two washes in 
0.1% Saponin (Sigma-Aldrich) (w/v in PBS), the slides were incubated  with corresponding 
fluorophore-conjugated secondary antibodies (Invitrogen, Thermo Fischer Scientific) diluted in 
blocking buffer at room temperature for 1 hour and counterstained with DAPI (D1306; Thermo 
Fischer Scientific). The slides were subsequently mounted in Prolong Gold Anti-fade reagent 
(P36930; Thermo Fisher Scientific). The slides were acquired on CLSM SP8 upright Leica 
confocal laser scanning microscope equipped with either a HCX PL APO Leica 40X NA 1.4 oil 
immersion objective or a Leica APO 63x NA 1.4 oil immersion objective at a definition of 
1024x1024 pixels. After acquisition, the images were processed with Adobe Photoshop (version 
CS5, Adobe System Inc.) software. Quantitative image analysis was performed by selecting 
randomly 10 - 20 visual fields per each slide that included at least 4-10 PT sections, using the 
same setting parameters (i.e. pinhole, laser power, and offset gain and detector amplification 
below pixel saturation). Quantification was performed using the open-source cell image analysis 
software CellProfiler (Carpenter et al, 2006). 
The cells on chambers slides were fixed for 10 min in 4% paraformaldehyde (Sigma-Aldrich,) in 
PBS, permeabilized and quenched with 50 mM NH4Cl for 30 min in blocking buffer (50 mM 
NH4Cl, 0.1% (w/v) saponin, 3% (w/v) BSA in PBS). The cells were then incubated 2 h with the 
desired primary antibody, washed six times in PBS, incubated for 1 h with the Alexa-labelled 
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secondary antibody and mounted on Vectashield covered coverslips (Vector Laboratories, 
Burlingame, CA, USA) using Prolong Gold Anti-fade reagent (P36930, Thermo Fisher 
Scientific). Quantitative image analysis was performed by selecting randomly five visual fields 
pooled from biological triplicates, with each field including at least 20–25 cells, using the same 
setting parameters (i.e., pinhole, laser power, and offset gain and detector amplification below 
pixel saturation).  
Primary cilia measurement. Z-stack images were acquired with Leica APO 63x NA 1.4 oil 
immersion objective with the lower and the upper limit of the stack comprise all the focal planes 
with acetylated-tubulin staining. After the Z-stack acquisition, a maximum projection image was 
generated and the ciliary length was measured using ImageJ/Fiji (https://imagej.nih.gov/ij/). In 
primary cell culture, at least 50 cilia per experimental conditions were measured before any 
statistical analyses. (Satir & Pampliega, 2016) 
Flow stimulation. Differentiated proximal tubular cell monolayers were exposed to orbital motion 
by placing 6-well plates on top of a shaker table in a standard laboratory incubator set at 37 °C 
with a frequency of 1Hz for various amount of time. After the stimulation period, cells were 
either processed for western blotting of subjected to an uptake assay and further processed for 
immunofluorescence. (Kolb et al, 2004) 
Antibodies. Unless specify otherwise, all the antibody were used at a 1:500 dilution for 
immunoblotting and western blot. The following antibodies were used in this study: mouse anti-
rat PCNA (Dako, Glostrup, Denmark), rabbit anti-human DBP (Dako), rabbit anti-human TF 
(Dako), rabbit anti-Uteroglobulin (Abcam, Cambridge, UK), mouse anti-β-actin (Sigma, St. 
Louis, USA), rabbit anti-human AQP1 (Millipore, Billerica, USA), rabbit anti-AQP2 (Sigma) 
rabbit anti-Rab5 (Abcam), rabbit anti-Rab7 (Abcam), rabbit anti-SGLT2 (Abcam), rabbit anti-
IFT20 (proteintech, Manchester, UK), rabbit anti-IFT88 (proteintech), mouse anti-acetylated 
tubulin (Abcam), mouse anti-ubiquitin (Santa Cruz Biotechnology, Texas, USA), goat anti-
cathepsin-D (Santa Cruz Biotechnology), rabbit anti-ATG7 (Santa Cruz Biotechnology), rabbit 
anti-p62 (MBL internationlal, Woburn, MA, USA), rabbit anti-LC3 (MBL international), mouse 
anti-human Ki-67 (Dako). Sheep anti-megalin was kindly provided by Prof. Verroust, INSERM, 
Paris, France and rabbit anti-NaPi-IIa by CA Wagner, University of Zürich. 
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Immunoblotting. Proteins were extracted from frozen kidneys or primary PT cell cultures lysed in 
RIPA buffer (Sigma Life Technologies) containing protease and phosphatase inhibitors (Roche 
Diagnostics, Mannheim, Germany), followed by a brief sonication and centrifugation at 
16’000xg for 1min at 4°C. Protein concentration was determined using the Pierce BCA protein 
assay (Pierce Thermo Fischer Scientific). Samples normalized and diluted in Laemmli sample 
buffer (Bio-Rad) containing Dithiothreitol (DTT, PanReac AppliChem, Barcelona, Spain), and 
proteins were separated by SDS-PAGE and subsequently blotted onto polyvinylidene difluoride 
membranes. Membranes were blocked for 30 min in 5% non-fat dry milk (1706404, Bio-Rad 
Laboratories) solution at room temperature, followed by overnight incubation of primary 
antibodies at 4°C. Blots were washed and incubated with peroxidase-conjugated secondary 
antibodies for 1h, washed again and incubated with chemiluminescent HRP substrate (Merck, 
Darmstadt, Germany). Immunoblots were quantified by densitometry using ImageJ software. 
Immunoprecipitation: The cells were lysed in a buffer containing 25 mM Tris/HCl adjusted to pH 
7.4, 150 mM NaCl, 1% NP-40, and 1 mM EDTA, 5% glycerol, protease and phosphatase 
inhibitors for 10 min at 4 °C. Lysates were centrifuged at 12,000 G. for 10 min and the 
supernatants were incubated with 1.5 μg of primary anti-megalin antibody for 16 h at 4 °C. After 
addition of 50 μl of protein G sepharose beads (P9424, Sigma), lysates were incubated at 4 °C for 
12 h with gentle shaking. Agarose beads were washed for three times and then collected through 
centrifugation at 12,000 G. for 1 min. Beads were reduced by the addition of 35 μl of Laemmli 
sample buffer, heated at 95 °C for 5 min, and resolved on 10% SDS-polyacrylamide gel 
electrophoresis (PAGE) gel, and analyzed by western blotting. 
Data analyses and Statistics. The quantitative data were expressed as means ± SEM. Differences 
between experimental groups were evaluated using one-way analysis of variance followed by 
Bonferroni or Dunnet’s post hoc test, when appropriate. When only two groups were compared, 
unpaired or paired two-tailed Student’s t-tests were used as appropriate. No statistical methods 
were used to predetermine the sample size. We estimated the sample size considering the 
variation and mean of the samples. Assumptions for statistical analyses were met (that is, normal 
distribution and equal variance). The sample size (number of cells or number of biological 
replicates derived from distinct mice or rats) of each experimental group is described in figure 
legends. The results are representative of at least three independent experiments, unless specified 
in the figure legends. None of the samples/animals was excluded from the experiment, and the 
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animals were not randomized. The investigators were not blinded to allocation during the 
experiments and outcome assessment. GraphPad Prism software was used for all statistical 
analyses. Statistical differences were considered significant at a P < 0.05. 
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Table 1: Clinical and biological parameters in the HAN:SPRD rats. 
 
 
5 weeks old 9 weeks old 
Parameter  +/+  Cy/+  +/+  Cy/+  
Diuresis (µL/g 
BW/12 h)  
17.1±0.9 32±8.9 22.9±3.5 35±5.3 
U Albumin(μg/mg 
creatinine)  
0.17±0.05 0.87±0.68 2.0±0.48 77.29±35.01* 
U calcium (g/mg 
creatinine)  
2.2±0.40 1.9±0.20 1.79±0.39 2.47±0.34 
U glucose (mg/mg 
creatinine)  
0.76±0.06 0.67±0.03 0.88±0.09 0.83±0.09 
BUN (mg/dL)  38.1±2.6 37.6±2.3  34±1.91 68±5.52*** 
 
Parameters represent the mean ± SEM of 5 - 8 animals per group. Statistical difference between 
groups were calculated with unpaired Student’s t test, *P<0.05; **P<0.01; ***P<0.001 
U, urine; BUN, blood urea nitrogen. 
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Table 2: Body weight and urine parameters in ksp-Cre;Pkd1
del2–11,lox
 and control mice.  
Parameter  Pkd1 +/+  Pkd1
del2–11,lox
   
Body weight (g)  22.66±2.22 23.98±2.63 
U volume (mL/24 h)  1.66±0.34 1.92±0.46 
U CC16 (μg/mg creatinine)  4.54±1.57 27.16±6.86** 
U calcium (g/mg creatinine)  1.2±0.30 1.4±0.20 
U phosphate (mg/mg creatinine)  2.50±1.11 2.65±0.26 
U glucose (mg/mg creatinine)  2.32±0.44 2.01±0.40 
U creatinine (mg/dL)  41.05±2.07 50.51±3.64 
 
Parameters represent the mean ± SEM of 5 animals per group. Statistical difference between 
groups were calculated with Mann-Whitney test, *P<0.05; **P<0.01; ***P<0.001 
U, urine;  
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Table 3: Clinical and biological parameters of individuals with ADPKD.  
 
ID Gender Age 
Mutated 
Gene 
Mutation Mutation type 
Plasma 
Creatinine 
(mg/dl) 
U Creatinine 
(mg/dl) 
Microalbumin 
(μg/g creat) 
eGFR  
(ml/min) 
110 F 22 PKD1 c.9914_9915del frameshift 0.68 216.67 513.68 124 
37 F 38 PKD1 c.9241T>C     (p.Cys3081Arg) missense 0.61 162.57 63.36 110 
788 M 26 PKD1 c.8311G>A (p.Glu2771Lys) missense 0.85 123.27 6.49 120 
103 F 28 PKD1 c.11661 dup(p.Phe3888Leufs*73) frameshift 0.53 124.69 8.02 137 
106 F 30 PKD1 c.12711C>A p.(Tyr4237*) nonsense 0.74 176.16 60.74 109 
421 F 21 PKD1 
c.8537C>A  
p.Thr2846Asn 
missense 0.71 138.06 16.66 104 
101 F 23 PKD1 c.7343T>C  p.(Leu2448Pro) missense 0.57 156.7 11.49 132 
445 F 27 PKD1 c.8945dup (p.Ser2984Glufs*85) frameshift 0.6 142.53 25.26 126 
159 F 31 PKD1 c.6307C>T (p.Gln2103*) nonsense 0.58 227.91 9.21 123 
447 F 24 PKD1 c.12003+14_12003+33del 
atypical splice 
site 
0.58 27.14 18.42 129 
54 F 27 PKD1 deletion of exon 1 
large 
rearrangement 
0.67 99.41 19.11 106 
30 M 32 PKD1 c.2955-2958del (p.Tyr986fs) frameshift 0.96 110.27 4.53 91 
473 M 19 PKD1 
c.5968_5969del 
p.(Arg1990Glufs*59) 
frameshift 0.99 307.57 9.10 97 
136 M 21 PKD1 c.11485_11487del p.Glu3829del small IF indels 0.96 240.21 8.74 98 
301 F 24 PKD1 c.3623T>A(p.(Val1208asp)) missense 0.66 146.68 21.82 110 
993 F 33 PKD2 c.952dup (p.Val318Glyfs*23 frameshift 0.78 319.22 26.63 100 
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Figure 1: Defective receptor-mediated endocytosis in Han:SPRD Cy/+ rat 
(A) Representative immunoblots of low molecular weight proteinuria (LMWP): transferrin, vitamin D-binding protein (VDBP) and Clara cell protein 16 (CC16) in urine samples 
from +/+ and Cy/+ rats (normalized to 5 μg creatinine). n = 4 rats per group (5-6 weeks old). (B) Urinary CC16 concentration was measured by ELISA in +/+ and Cy/+ (6-7 
animals per group). Statistical differences between groups were measured with unpaired Student’s t test. ***P<0.001 versus +/+. (C) Representative immunoblots for megalin, 
aquaporin-1 (AQP1), rab5, rab7, proliferative cell nuclear antigen (PCNA) and β-actin in +/+ and Cy/+ kidneys (25 μg total protein per lane, n = 5 rats per group). Unpaired 
Student’s t test was used to assess statistical differences with *P<0.05 versus +/+, **P<0.01 versus +/+ (taken as 100%). (D) Immunofluorescence for megalin, AQP1 and KI67 
in +/+ and Cy/+ kidneys. Nuclei were counterstained with DAPI. Quantification of KI67 positive nuclei was performed on >20 PTs per condition. Scale bar: 50 μm (E) Uptake of 
Alexa488-bovine serum albumin (BSA) and Alexa488-Dextran in rPTC derived from +/+ and Cy/+ kidneys. Quantification of BSA positive vesicles was performed on >400 
cells using CellProfiler. Statistical differences were calculated with unpaired Student’s t test with ***P<0.001. Scale bar: 20 μm (F) Representative immunoblots for megalin, 
SGLT2, ClC-5, NaPi-IIa, Rab5, Rab7, PCNA and β-actin. n = 4 animals per group. Unpaired Student’s t test was used for statistical analyses.  
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Figure 2: Defective ciliogenesis impairs megalin expression and endocytosis 
(A) Representative immunofluorescence for acetylated-tubulin and AQP1 in +/+ and Cy/+ kidneys. Ciliary length was measured with ImageJ on > 100 cilia. Statistical differences 
were assessed with Student’s t test with ***P<0.001 Scale bar: 10 μm (B) +/+ and Cy/+ derived rPTCs were subjected to apical fluid movement (flow, 1 Hz, 4h) followed by an 
endocytosis assay of Alexa647-BSA. Immunofluorescence for acetylated-tubulin on rPTC derived from +/+ and Cy/+ kidneys. Ciliary length was measured with ImageJ on 350 
cilia. Quantification of BSA positive vesicles was performed on > 400 cells using CellProfiler. Statistical differences were measured using one-way analysis of variance and 
Turkey’s range test (post-hoc) with ***P<0.001 Scale bar: 10 μm (C) Representative immunoblots  for megalin in +/+ and Cy/+ derived rPTCs after 0, 1, 2 and 4h of apical fluid 
movement (flow, 1Hz). n = 3 independent experiments. Statistical differences were assessed with unpaired Student’s t test with ***P<0.001 Cy/+ vs +/+ control and #p<0.001 +/+ 
under flow vs +/+ control (D) Representative immunoblots for IFT20, IFT88 and β-actin in +/+ and Cy/+ derived rPTCs (25 μg total protein per lane). n = 3 independent 
experiments. Statistical differences were assessed with unpaired Student’s t test with ***P<0.001 (E) Quantitative RT-PCR to measure the mRNA expression of Ift20, Ift88 and 
Kif3a. (F) Representative immunoblots for megalin and IFT20 in +/+ and Cy/+ derived rPTCs after treatment with Ad-IFT20-shRNA. n = 4 independent experiments. Statistical 
differences were assessed with unpaired Student’s t test with *P<0.05, **P<0.01 and ***P<0.001 (G) Uptake of Alexa647-BSA in +/+ and Cy/+ rPTCs transduced with Ad-Scmb 
or Ad-Ift20-shRNA. Quantification of BSA positive vesicles and ciliary length measurement were performed on 200 cells per condition using cellProfiler and imageJ respectively. 
Scale bar: 10 μm (H) Representative immunoblots for megalin, ubiquitin and β-actin in +/+ and Cy/+ derived rPTCs treated or not with 5 μM of MG-132 for 24h and 48h. n = 3 
independent experiments. Statistical differences were measured with Student’s t test with *P<0.05. 
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Figure 3: Defective autophagy leads to an accumulation of the ciliary protein IFT20 
 (A) Representative immunoblots and densitometry analyses of p62, LC3 and β-actin in +/+ and Cy/+ kidneys (25 μg total protein per lane). n = 4 pairs of 5 - 6 weeks old rats. Scale 
bar: 50 μm (B) Immunofluorescence of Lotus Tetragonolobus Lectin (LTL), p62 and LC3-positive vesicles in kidney sections of 5 weeks old Cy/+ and +/+ animals. Nuclei were 
counterstained with DAPI. Quantification of LC3+ and p62+ vesicles was performed on > 80 LTL positive PTs. (C) Representative immunoblots and densitometry analyses of p62, 
LC3, IFT20 and β-actin in +/+ and Cy/+ derived rPTCs cultured in nutrient-rich medium or in nutrient-depleted medium for 4 h, in presence or absence of 250 nM of BafilomycinA1. 
25 μg total proteins per lane were used and the experiment was repeated 3 times. Statistical differences between experimental conditions were measured with Student’s t test with 
**P<0.01 and ***P<0.001 versus +/+ in nutrient-rich medium. (D) Representative electron micrograph of +/+ and Cy/+ derived rPTCs. Scale bar = 2 μm. (E) +/+ and Cy/+ derived 
rPTCs were transduced with GFP-tagged Map1lc3b (Map1lc3b/GFP, green) bearing adenoviral particles for 48 h. The cells were subsequently incubated in nutrient-rich medium or 
in nutrient-depleted medium for 4 h, in presence or absence of 250 nM of BafilomycinA1. The colocalization of GFP-LC3 and IFT20 was monitored by confocal microscopy,  the 
identification and quantification of GFP-LC3 - IFT20 positive vesicles were performed on >500 autophagosomes per conditions using CellProfiler. 
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Figure 4: Lysosomal dysfunction causes defective autophagy clearance and abnormal ciliogenesis  
(A) 5 weeks-old +/+ and Cy/+rats were injected with 100 μg of Lactoglobulin-Cy5 and the kidneys were harvested after 15 and 120 min and further process for 
immunofluorescence of AQP1 and Lactoglobulin-Cy5. Quantification of Lactoglobulin-Cy5 vesicles was performed on 20 AQP1 positive PTs per conditions. Scale bar: 20 μm 
(B) Representative immunoblots of cathepsin-D and β-actin on +/+ and Cy/+ derived rPTCs cultured in nutrient-rich medium or in nutrient-depleted medium for 4 h, in presence 
or absence of 250 nM of BafilomycinA1. n = 3 independent experiments (C) +/+ and Cy/+ derived rPTCs were incubated with 2 nM of Magic Red substrate or FL-Bodipy 
pepstatinA (PepA) for 1h fixed and further process for immunofluorescence. Quantification was performed on > 200 cells per conditions. Scale bar = 10 μm (D) Representative 
immunofluorescence of acetylated-tubulin of mouse primary PT cells (mPTCs) incubated for 24 h with 25 μg.mL-1 of renal fanconi syndrome (RFS) associated human κ light 
chains (κCH) or a non-pathogenic mutant version of κCH (κCHm). Ciliary length was measured with ImageJ on 150 cilia per conditions. Statistical differences between groups 
were assessed with Student’s t test with ***P<0.001. (E) Representative immunoblots for IFT20, p62 and β-actin in mPTCs incubated for 24 h with κCHm or κCH. Statistical 
difference between groups were calculated with Student’s t test with***P<0.001. Scale bar: 20 μm (F) Representative immunofluorescence of acetylated-tubulin, IFT20 and 
AQP1 in Ctns+/+ and Ctns-/- kidney sections. Primary cilia length was measured on >100 cilia distributed in 40 AQP1 positive PTs. Quantification IFT20 + vesicles was 
performed on >20 tubules per conditions. Statistical difference between groups were calculated with Student’s t test with***P<0.00. Scale bar: 50 μm 
 
81 
 
 
  
Figure 5: Dent disease mouse model exhibits impaired ciliogenesis 
(A) Representative immunofluorescence of Acetylated-tubulin and AQP1 in Clcn5Y/+ and Clcn5Y/- kidney sections. Primary cilia length was measured on 100 cilia distributed in 
20 AQP1 positive PTs per conditions. Statistical difference between groups were calculated with Student’s t test ***P<0.001. Scale bar: 10 μm (B) Representative 
immunofluorescence of acetylated-tubulin in mPTCs derived from Clcn5Y/+ and Clcn5Y/- Scale bar: 10 μm (C) Representative immunoblots of IFT20, p62, Rab5 and β-actin in 
Clcn5Y/+ and Clcn5Y/- derived mPTCs.  Statistical difference between groups were calculated with Student’s t test with *P<0.05, **P<0.01 versus Clcn5Y/+ mPTCs 
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Figure 6: Autophagy regulates primary cilia length and endocytosis activity 
(A) Uptake of Alexa647-bovine serum albumin (BSA) followed by an immunofluorescence of Acetylated-tubulin in mPTCs cultured in absence of nutrients for 0 (FM, full 
medium) 2, 4 and 8 h. >100 cells per conditions were used for quantification purposes. Statistical difference between groups were calculated with Student’s t test with **P<0.01 
STV versus FM and ***P<0.001 STV versus FM. Scale bar: 20 μm (B) Representative immunoblots of megalin and β-actin in mPTCs cultured in absence of nutrients for 0, 2, 
4, 8 and 24 h. n=3 independent experiment. Statistical difference between groups were calculated with Student’s t test with *P<0.05 **P<0.01 and ***P<0.001. (C)  
Representative immunoblots and densitometry for ATG7, p62, LC3 and β-actin in mPTCs derived from Atg7fl/fl mice transduced with Ad-Cre or Ad-Scmb. n=4 independent 
experiments. Statistical difference between groups were calculated with Student’s t test with *P<0.05 and ***P<0.001 (D) Immunofluorescence for acetylated tubulin in mPTCs 
derived from Atg7fl/fl mice transduced with ad-Cre or Ad-Scmb. Ciliary length was measured on about 200 cells. Statistical difference between groups were calculated with 
Student’s t test with***P<0.001. Scale bar: 20 μm  
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Figure 7: ksp-Cre;Pkd1
del2–11,lox
  mouse model recapitulates defective autophagy and endocytosis 
(A) Representative immunoblots of transferrin and vitamin D binding protein (DBP) in urine from ksp-Cre;Pkd1del2–11,lox mice and their control littermates (Normalized to 5 μg 
creatinine). n=4 animals per group (B) Urinary CC16 was measured by ELISA. n=4 animals per group. (C) Representative immunoblots for megalin, Rab5, Rab7, AQP1, 
IFT20 and β-actin in kidney samples from Cre;Pkd1del2–11,lox mice and their control littermates. 25µg of protein was loaded per lane. n = 4 animals per group. Statistical 
difference between groups were calculated with Student’s t test with *P<0.05 (D) Immunofluorescence of PCNA and AQP1 in kidney sections from Pkd1 deficient mice and 
control mice. Quantification was performed on 20 AQP1 positive PTs per conditions and statistical difference between groups were calculated with Student’s t test with 
***P<0.001. Scale bar: 50 μm (E) Endocytosis assay monitoring Alexa488-BSA uptake in mPTCs derived from 8 weeks-old ksp-Cre;Pkd1del2–11,lox mice and control mice. 
Quantification of BSA positive vesicles was performed on 100 cells per condition. Statistical differences were calculated with unpaired Student’s t test with ***P<0.001. Scale 
bar: 20 μm (F) Immunofluorescence of Acetylated-tubulin in mPTCs from ksp-Cre;Pkd1del2–11,lox mice and controls. Primary cilia length was measured on > 100 cilia. (G) 
Immunofluorescence of p62 and LC3 in kidney sections from ksp-Cre;Pkd1del2–11,lox mice and their respective controls. Quantification of LC3+ and p62+ vesicles was 
performed on 20 AQP1 positive PTs per conditions and statistical difference between groups were calculated with Student’s t test with ***P<0.001. Scale bar: 50 μm 
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Figure 8: ADPKD patients show PT dysfunction in absence of renal failure 
(A) Microalbuminuria was measured in urinary samples from 16 ADPKD patients and 9 healthy volunteers. Values were normalized to creatinine concentration. Statistical 
differences were assessed with Mann-whitney test with ***P<0.001. (B) Representative immunoblots for transferrin and vitamin D binding protein (VDBP) in urinary samples 
from 16 ADPKD patients and 6 healthy volunteers. Loading was normalized to creatinine concentration (20 μg per lane). (C) Representative immunofluorescence of Acetylated-
tubulin and AQP1 in kidney sections from ADPKD patients and control. Primary cilia length was measured on 50 cilia distributed in 20 AQP1 positive PTs. Statistical difference 
between groups were calculated with Student’s t test ***P<0.001 Scale bar: 25 μm (D) Representative immunofluorescence of megalin in kidney sections from ADPKD patients 
and control. Scale bar: 25 μm 
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Model of interplay between ciliogenesis, receptor-mediated endocytosis and autophagy 
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Supplementary Figure 1: Characterization of Han:SPRD Cy/+ rats kidney phenotype 
(A) Urinalysis of diuresis, phosphaturia and microalbumiuria in +/+ and Cy/+ rats at 4 and 9 weeks old. Data are represented as mean +/- SEM. Statistical differences between 
groups were assessed with Student’s t test with ***P<0.001. n=5-9 animals per group. (B) Representative haematoxylin and eosin staining of kidney sections from 4 and 9 weeks 
old +/+ and Cy/+ rats.   (C) Quantitative RT-PCR to measure the mRNA expression of PT (Lrp2, Cubn, Sglt2, Clcn5, and Pkdr1) and proliferation (Pcna and Ccnd1) genes in 
+/+ and Cy/+ whole kidneys. n = 4 rats per group. Statistical differences between groups were assessed with Student’s t test with *P<0.05, **P<0.01.  
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Supplementary Figure 2: Characterization of rPTCs derived from Han:SPRD Cy/+ kidneys 
(A) Representative immunoblots for podocin (NPHS2), aquaporin-1 (AQP1), sodium, potassium, chloride cotransporter 2 (NKCC2), aquaporin-2 (AQP2) and β-actin in rat 
primary culture of proximal tubular cell (rPTCs) and in kidney. 25 μg proteins per lane were used. Experiments were performed on rPTCs derived from 3 rats. (B) Uptake of 
0.01, 0.05, 0.1 and 0.5 mg.mL-1 of Alexa488-bovine serum albumin (BSA) in +/+ derived rPTCs. Additionally, rPTCs were also treated with 80 μM of dynasore, a dynamin 
GTPase inhibitior known to block endocytosis, at 37 °C 30 min prior to the endocytosis assay. >500 cells were used for statistical analyses. Michaleis-Menten kinetics model 
was used to monitor the endocytosis activity. (C) Quantitative RT-PCR to measure the mRNA expression of PT (Lrp2, Cubn, Clcn5, and Pkdr1) and proliferation (Pcna and 
Ccnd1) genes in +/+ and Cy/+ whole kidneys. n = 4 rats per group. Statistical differences between groups were assessed with Student’s t test with *P<0.05, **P<0.01. 
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Supplementary Figure 3: Alteration of primary cilia impairs endocytosis and decrease megalin expression 
(A) Uptake of Alexa647-bovine serum albumin (BSA) and Alexa647-Dextran followed by an immunofluorescence of Acetylated-tubulin in mPTCs treated or not with 100nM 
cytochalasin D (CytoD) for 8h.  >100 cells were used per condition for quantification. Scale bar: 20 μm (B) Representative immunoblots of megalin and Rab5 in mPTCs after 0, 
4h and 8h of CytoD treatment (25μg total protein per lane). (C) Immunoprecipitation of megalin from mPTCs treated or not with 100nM of cytochalasin D and immunoblotting 
of ubiquitin. n= 4 independent experiments (D) Representative immunofluorescence of Acetylated-tubulin in mPTCs treated with 0 (control), 5, 10 or 30 mM of ammonium 
sulfate (NH4SO4) for 12 h. Cilia length was measured on at least 50 cilia per conditions. Statistical differences were measured with Student’s t test with *P<0.05. Scale bar: 20 
μm (E)  Uptake of Alexa647-bovine serum albumin (BSA) followed by an immunofluorescence of acetylated-tubulin in mPTCs treated with 30 mM of  NH4SO4  for 0, 8 and 12 
h. 100 cells per condition were used for quantification purposes. Statistical differences were measured with Student’s t test with *P<0.05, **P<0.01 and ***P<0.001. Scale bar: 
10 μm (F) Representative immunoblots for megalin and β-actin for mPTCs treated with 30 mM of NH4SO4 for 0, 8 and 12h. n = 3 independent experiments. Statistical 
differences were measured with Student’s t test with ***P<0.001 versus control 
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Supplementary Figure 4: mTOR activity in Cy/+ derived rPTCs 
Representative immunoblots for phospho-Ulk1 (pULK1), ULK1, phosphor-S6 kinase (pS6K), S6 kinase (S6K) and β-actin in rat primary culture of proximal tubular cell 
(rPTCs) cultured in nutrient-rich medium (Fed) or in nutrient-depleted medium (Stv). Statistical differences were measured with Student’s t test with *P<0.05 and **P<0.01 
versus +/+ derived rPTCs in Stv conditions. 
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ABSTRACT  
Dent disease is a rare X-linked tubulopathy caused by mutations in the endosomal chloride-
proton exchanger ClC-5, resulting in defective receptor-mediated endocytosis and severe 
proximal tubule (PT) dysfunction. Bone marrow (BM) transplantation has recently been 
shown to preserve kidney function in cystinosis, a lysosomal storage disease causing PT 
dysfunction. In this study we tested the effects of BM transplantation in Clcn5
Y/- 
mice, a 
faithful model for Dent disease. Wild-type BM transplantation in Clcn5
Y/- 
mice significantly 
improved PT dysfunction, with decreased low-molecular-weight proteinuria, glycosuria, 
calciuria and polyuria four months after transplantation, compared to Clcn5
Y/- 
mice 
transplanted with ClC-5 knock-out BM. The BM-derived cells engrafted in the interstitium, 
surrounding PT cells which showed a rescue of the apical expression of ClC-5 and megalin 
receptors. The improvement of PT dysfunction correlated with Clcn5-gene expression in 
kidneys of mice transplanted with wild-type BM cells. Co-culture of Clcn5
Y/- 
PT cells with 
BM-derived cells confirmed rescue of ClC-5 and megalin, and resulted in improved 
endocytosis. Nanotubular extensions between the engrafted BM-derived cells and PT cells 
were observed in vivo and in vitro. No rescue was observed when the formation of the 
tunneling nanotubes was prevented by actin depolymerisation or when cells were physically 
separated by transwell inserts. These data provide the first demonstration that BM 
transplantation may rescue the epithelial phenotype due to an inherited endosomal defect. 
Direct contacts between BM-derived cells and diseased tubular cells play a key role in the 
rescue mechanism. 
 
Keywords: Low-molecular weight proteinuria; bone marrow cell; renal Fanconi syndrome; 
ClC-5; proximal tubule.  
93 
 
INTRODUCTION 
The epithelial cells lining the proximal tubules (PT) of the kidney constitute a paradigm of 
effective communication between the external environment and the endomembrane system 
(1). By processing incoming substances, and recycling receptors and transporters at the apical 
membrane, the connecting endolysosomal system governs the terminal differentiation of PT 
cells and the recovery of essential substances that would be otherwise lost in the urine (2). 
These substances include low-molecular-weight (LMW) proteins, which are filtered and then 
completely reabsorbed by apical endocytosis involving the multi-ligand receptors megalin 
and cubilin. Following binding and internalization, ligands are delivered to endosomes and 
further to lysosomes for processing and degradation, so that PT cells play a pivotal role in 
homeostasis (3). Alterations in these transport processes can lead to a generalized PT 
dysfunction (renal Fanconi syndrome, RFS), characterized by urinary loss of solutes 
including LMW proteins, glucose and phosphate, and is often complicated by dehydration, 
electrolyte imbalance, rickets, and development of chronic kidney disease. Such PT 
dysfunction is typically encountered in congenital disorders of the endolysosomal 
compartment, including Dent disease and nephropathic cystinosis (4). 
 Dent disease (MIM #300009) is a rare, X-linked disorder characterized by LMW 
proteinuria, generalized PT dysfunction, kidney stones, and renal failure (5). The disease is 
caused by inactivating mutations of the CLCN5 gene that encodes ClC-5, an electrogenic Cl
-
/H
+
 exchanger that is located in the early endosomes of PT cells (6), where it regulates 
vesicular Cl
−
 concentration potentially affecting the activity of the V-ATPase and/or vesicle 
recycling (7). Studies in Clcn5
Y/-
 mice, which represent a faithful model of Dent disease, 
demonstrated that the functional loss of ClC-5 induced a severe loss of megalin and cubilin at 
the brush border membrane, with impaired endocytosis and lysosomal processing of 
internalized ligands in PT cells (8,9). The defective endocytosis and apical transport 
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processes explain why solutes are lost in the urine, often resulting in RFS. In the absence of 
therapy targeting the molecular defect, the current care of patients with Dent disease is solely 
supportive, focusing on the prevention of metabolic complications and nephrolithiasis. 
Recently, bone marrow (BM) and hematopoietic stem cell (HSC) transplantation have 
been shown to preserve kidney function in nephropathic cystinosis, the most frequent cause 
of RFS in children (10,11). Cystinosis (MIM #219800) is caused by autosomal recessive 
mutations in the CTNS gene, which encodes cystinosin, a lysosomal cystine-proton 
cotransporter exporting cystine into the cytosol. Functional loss of cystinosin results in 
lysosomal accumulation of cystine crystals leading to progressive dysfunction of multiple 
organs including the kidney. Children with nephropathic cystinosis, the most severe and 
frequent form of cystinosis, develop PT dysfunction and RFS before 1 year of age, often 
followed by chronic kidney disease (CKD) (12). Healthy BM-derived cells decreased cystine 
levels in the kidneys of diseased mice and improved several serum and urinary parameters in 
relation to the level of engraftment (11). Subsequently, in vitro studies suggested that 
vesicular cross-correction mediated by transfer of cystinosin-bearing lysosomes could sustain 
the correction (13,14). Whether BM transplantation could improve the epithelial phenotype in 
other congenital defects of the endolysosomal pathway - in particular those that are not 
associated with lysosomal storage - is unknown. Furthermore, the mechanism of rescue, 
without evidence of target tissue differentiation and replacement of damaged cells, remains a 
major issue in stem cell transplantation (15). 
 Based on the encouraging results in cystinosis, we tested the effects of BM 
transplantation in the well-established Clcn5
Y/-
 mouse model of Dent disease and used a co-
culture system to analyse the potential mechanisms involved.  
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RESULTS 
Protocol and hematopoietic chimerism 
To test whether BM transplantation improves the PT dysfunction associated with Dent 
disease, we transplanted 10-weeks old ClC-5 knockout (KO) male (Clcn5
Y/-
) mice with wild-
type (WT) green fluorescent protein (GFP)-expressing BM cells (“treated”). As controls, 
Clcn5
Y/-
 mice were transplanted with KO BM cells from Clcn5
Y/-
 mice (“negative controls”) 
and age- and gender-matched WT littermates (Clcn5
Y/+
) were transplanted with WT-BM cells 
(“positive controls”) (Fig. 1A). Urine and plasma were collected at baseline (one week prior 
to transplantation), and then 10 weeks and 16 weeks after transplantation. Since recipients 
were lethally irradiated per protocol, BM transplantation resulted in full multilineage 
hematopoietic chimerism in peripheral blood in all mice, as shown by a nearly 100% myeloid 
and B cell chimerism (Fig. 1B). 
 
Improvement of PT dysfunction in Clcn5
Y/-
 mice transplanted with BM cells 
As previously described (9,16), Clcn5
Y/- 
mice exhibited features of PT dysfunction including 
polyuria, glycosuria, hypercalciuria and LMW proteinuria (detection of 16kD Clara Cell 
protein, CC16), as compared to WT littermates at baseline (Table 1).  
In order to assess the potential effect of BM transplantation, we analysed markers of PT 
dysfunction over time in treated vs. negative control Clcn5
Y/- 
mice (Fig. 2; Table 1). Over the 
16-week observation, the negative controls (Clcn5
Y/- 
mice transplanted with KO-BM) showed 
a significant increase in diuresis and in urinary excretion of CC16, pointing towards 
progression of the disease over time. In contrast, the transplanted Clcn5
Y/- 
mice showed no 
significant change in diuresis and a significant reduction (~30% decrease) in the urinary 
excretion of CC16. Similarly, glycosuria and calciuria decreased significantly in transplanted 
animals, while these parameters were unchanged in negative controls. These data show a 
96 
 
significant improvement of PT dysfunction in mice transplanted with WT BM cells compared 
to negative controls.  
The biological effect of BM transplantation was reflected by the engraftment of BM-derived 
cells into Clcn5
Y/-
 kidneys (Fig. 3). The Clcn5
Y/-
 mice displayed a significantly higher 
recruitment of GFP+ BM-derived cells into the kidneys than Clcn5
Y/+
 mice, at the mRNA and 
protein levels and confirmed by immunofluorescence for GFP (Figs. 3A-B).  
 
Recovery of megalin and ClC-5 in kidneys of BM-transplanted Clcn5
Y/-
 mice 
Since filtered LMW proteins are reabsorbed by receptor-mediated endocytosis in PT cells, 
the reduced urinary loss of CC16 in transplanted mice suggests that the endocytic machinery 
is at least partially recovered. To test this hypothesis, we investigated the expression level of 
megalin in the kidneys (Fig. 4). Contrasting with the major, selective loss of megalin 
expression observed in control Clcn5
Y/-
 vs. Clcn5
Y/+
 kidneys, a strong rescue of megalin 
expression was detected by Western blot in Clcn5
Y/-
 kidneys of mice transplanted with WT 
BM cells (Fig. 4A). The rescue of megalin was specific, since the expression of aquaporin-1 
(AQP1) and the endosome catalyst Rab5 remained unchanged in all treatment groups. Of 
note, bone marrow transplantation had no effect on protein expression in any genotype.  
The rescue of megalin was confirmed by immunofluorescence staining of  kidneys in BM-
transplanted mice (Fig. 4B). Whereas almost no megalin staining could be detected in 
Clcn5
Y/-
 kidneys transplanted with KO BM cells, an appreciable rescue of megalin was 
observed in the brush border of PT cells in Clcn5
Y/-
 kidneys transplanted with WT BM cells.  
In parallel, a significant rescue of ClC-5 expression was observed in Clcn5
Y/-
 kidneys of mice 
transplanted with WT BM cells, as shown by immunoblot (Fig. 4A) and qPCR (Fig. 4C). The 
rescued ClC-5 in treated Clcn5
Y/-
 kidneys was confirmed by immunofluorescence staining at 
the brush border of PT cells (Fig. 4B) and - at high magnification - in subapical vesicles 
reminiscing of endosomes (Suppl. Fig. 1A). The staining for ClC-5 was partially overlapping 
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with that of megalin in PT cells (Suppl. Fig. 2). Of note, the degree of LMW proteinuria 
(monitored by the urinary loss of CC16) in the treated Clcn5
Y/-
 mice inversely correlated with 
the level of ClC-5 mRNA rescued in the kidneys (Fig. 4C).  
 
Engrafted cells are mononuclear phagocytes that closely associate to PT cells  
To further investigate the mechanisms driving the improvement in PT dysfunction, we 
analysed the location and identity of the BM-derived cells in Clcn5
 Y/-
  kidneys. Besides the 
fact that more BM-derived cells engrafted to the Clcn5
Y/-
 vs. Clcn5
Y/+
 kidneys (Fig. 3), the 
engrafted cells also showed a distinct distribution pattern. In Clcn5
Y/-
 kidneys, the 
transplanted cells were found to be clustering around PT profiles, in close contact with PT 
cells, whereas in Clcn5
Y/+
 kidneys the transplanted cells were interspersed in the interstitium 
without clear contact with PT sections (Fig. 5A). The different locations were confirmed by 
automated confocal image analysis, showing a lower average distance of GFP+ cells from PT 
cells in Clcn5
Y/-
 vs. Clcn5
Y/+
 kidneys, respectively (Fig. 5A).  
The nature of the engrafted cells was then assessed (Fig. 5B). All transplanted GFP+ cells 
were found in the interstitium. Since we transplanted a whole BM cell suspension, i.e. a 
mixture of HSCs, mesenchymal stromal cells (MSCs), differentiated lymphocytes and 
myeloid cells as well as their immature precursors, the engrafted cells may theoretically 
derive from MSCs present in the suspension. Such cells do not migrate into healthy tissues, 
but upon irradiation injury, increased recruitment into peripheral organs has been observed 
(17). In case of acute injury, MSCs have been recruited to the kidneys where they may persist 
for a long time (18). However, with their characteristic protrusions, the GFP-expressing cells 
phenotypically resembled dendritic cells (DCs) or macrophages rather than MSC-derived 
cells, which would be spindle-shaped and compact. As DCs and macrophages further possess 
overlapping functions during steady state in the kidney, these cells are often referred to as 
“mononuclear phagocytes” (19). We confirmed this identity by staining the kidney sections 
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for CD45, CD11c (DC marker) and F4/80 (macrophage marker) (Fig. 5B). Co-staining of 
these markers with GFP allowed the conclusion that these cells originated from the 
hematopoietic lineage. Conversely, there was no overlap between the GFP cells and the 
fibroblast marker -SMA (Fig. 5B). Furthermore, the engraftment efficiency of WT GFP+ 
BM cells and KO BM cells in Clcn5
Y/-
 kidneys was similar as shown in Suppl. Fig. 3. 
 
Rescue of receptor-mediated endocytosis in co-culture system 
In order to substantiate the rescue of PT function as observed in vivo, we established a co-
culture system based on primary cultures of PT cells (mPTCs) obtained from microdissected 
PT segments of Clcn5
Y/-
 kidneys (20). These cells were then co-cultivated for 2 days with 
BM-derived DCs/macrophages (BM-DC/M). These BM-DC/Mwere generated by 
stimulating either WT (GFP+) or KO BM cells for 7 days with granulocyte-macrophage 
colony-stimulating factor (GM-CSF, 30ng/mL), resulting in a mixed population of adherent 
phagocytic cells (Fig. 6A). Fully differentiated BM-DC/M expressed CD45 and F4/80 (Fig. 
6B) as well as ClC-5 and megalin (Suppl. Fig. 1B). During the differentiation process of 
freshly isolated BM cells into BM-DC/M, gradual upregulation of mRNA encoding for 
ClC-5 (Clcn5), for the macrophage/DC markers F4/80 (Adgre1), CD45 (Ptprc), CD11c 
(Itgax), and for the tunelling nanotube markers myosin Va (Myo5a) and Msec (Tnfaip2) was 
observed (Fig. 6C). 
Immunofluorescence staining revealed that, in comparison with Clcn5
Y/-
 mPTCs co-cultivated 
with KO BM-DC/M, co-culture of Clcn5Y/- mPTCs with WT BM-DC/Mshowed a rescue 
of megalin and ClC-5 expression, particularly evident in mPTCs close to GFP+ cells (Fig. 
7A, upper panel). The recovery of megalin and ClC-5 expression was confirmed by Western 
blot (Fig. 7A, lower panel), with a functional counterpart based on albumin (Alexa 647-BSA) 
uptake by the Clcn5
Y/-
 mPTCs (Fig. 7B). Compared to the very low level observed in Clcn5
Y/-
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mPTCs co-cultivated with KO BM-DC/M, there was a significant, ~50% rescue of albumin 
uptake in Clcn5
Y/-
 mPTCs co-cultivated with WT BM-DC/M, although this was still lower 
than the uptake by Clcn5
Y/+
 mPTCs co-cultivated with WT BM-DC/M (Fig. 7B).  
 
Nanotubes mediate the interaction between transplanted BM-derived cells and PT cells 
We finally investigated potential rescue mechanisms of PT dysfunction by the transplanted 
BM cells. Visualization of GFP allowed to evidence, both in vivo (Fig. 8A, panels a-d) and in 
vitro (Fig. 8A, panels e-g), the existence of cellular prolongations between the GFP+ BM-
derived cells and PT cells from the Clcn5
Y/-
 kidneys. These cellular prolongations resemble 
the tunnelling nanotubes that form intracellular bridges supporting the microtubule-mediated 
transfer of intracellular components, as previously described in BM transplantation 
experiments (14,21). Immunostaining experiments revealed that the GFP+ BM-derived cells 
established multiple contacts with PT cells in the Clcn5
Y/-
 kidneys (Fig. 8A, panel b), and that 
the nanotubes crossed the collagen IV-positive tubular basement membrane to establish direct 
contact with PT cells (Fig. 8A, panels c-d). In co-culture experiments, multiple tunneling 
nanotubes positive for tubulin were identifed between GFP+ BM BM-DC/M cells and 
mPTCs derived from Clcn5
Y/-
 mice (Fig. 8A, panels e-g). A few GFP+ structures were also 
detected in PT cells in transplanted kidneys and in mPTCs in co-culture (Suppl. Fig. 4). 
To explore the role of these nanotubular formations in the rescue mechanism, we blocked 
their formation by treating the mPTCs with the actin-depolymerising agent Latrunculin B 
(21). This treatment prevented the development of cellular prolongations (Fig. 8B), as well as 
the rescue of megalin and ClC-5 expression (Fig. 8C) and the recovery of endocytosis 
activity (Alexa 647-BSA uptake) in co-cultures of GFP+ BM-derived cells with Clcn5
Y/-
 
mPTCs (Fig. 8B). Furthermore, when the Clcn5
Y/-
 mPTCs were separated from the GFP+ 
BM-derived cells by using a transwell porous insert, we could not observe any rescue of the 
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endocytic activity (Fig. 8D). Taken together, these data suggest that the establishment of a 
direct contact between transplanted BM-derived cells and diseased PT cells, via tunnelling 
nanotubes, plays a key role in the rescue.  
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DISCUSSION 
The results presented here demonstrate, for the first time, that BM transplantation may rescue 
the epithelial phenotype caused by a genetic defect in an endosomal transporter. 
Transplantation of WT Clcn5
Y/+
 BM cells to Clcn5
Y/-
 mice significantly reduced the 
progression of LMW proteinuria, glycosuria, calciuria and polyuria, compared to Clcn5
Y/-
 
mice transplanted with KO Clcn5
Y/-
 BM. The BM-derived cells differentiated into 
mononuclear phagocytes engrafted into the interstitium, surrounding PT cells to which they 
connected via nanotubular prolongations. The rescue of the epithelial phenotype is reflected 
by the recovery of ClC-5 and megalin expression in PT cells of Clcn5
Y/-
 mice. Co-culture of 
Clcn5
Y/-
 derived PT cells with WT BM-derived cells confirmed the recovery of ClC-5 and 
megalin and that of receptor-mediated endocytosis. The rescue was abolished when the 
formation of tunneling nanotubes was prevented in vitro.  
Whereas the value of BM and HSC transplantation is clearly established for malignant 
and genetic diseases of the hematopoietic system (e.g. acute leukemia, sickle cell disease or 
severe combined immunodeficiency), it has also been successfully used for certain types of 
lysosomal storage diseases (LSDs). LSDs are a group of diseases that are characterized by 
enzyme deficiency in lysosomes, resulting in substrate accumulation and subsequent cellular 
dysfunction. Here, healthy cells derived from the transplanted hematopoietic system can 
engraft into various organs and through the close proximity with diseased cells, they can 
replace defective enzymes by secretion. In Hurler Syndrome (type 1 mucopolysaccharidosis) 
for example, HSC transplantation is being performed in patients for more than 30 years (22). 
Cystinosis is also a LSD, caused by the functional loss of the lysosomal transporter 
cystinosin, resulting in the accumulation of cystine crystals in multiple tissues and cell types. 
The seminal studies of Cherqui and colleagues have demonstrated the long-term renal 
protection conferred by BM and HSC transplantation in cystinosis (10,11). The main effect of 
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transplantation was the reduction of cystine crystals in tissues, while improvement of kidney 
function parameters were only modest without evidence for rescue of PT endocytic capacity 
(10,11). The effects were directly related to the number of phagocytic cells that engrafted in 
the kidneys (11).  
Here, we tested the effect of BM transplantation in Dent disease, a paradigm of 
congenital epithelial disorder caused by the loss of a vesicular (endosomal) transporter. Dent 
disease is particularly suited for an intervention protocol, as the defective endocytic uptake by 
PT cells is readily monitored by the detection of LMW proteins in urine, the most consistent 
feature of the disease in man and mouse (5,6,23). Transplantation of healthy BM significantly 
altered the progression of PT dysfunction in Clcn5
Y/-
 mice, as manifested most prominently in 
the decreased loss of CC16 in urine. This effect was related to the engraftment of BM-derived 
cells differentiated into monocluclear phagocytes, based on their co-expression of F4/80, 
CD11c and CD45. These cells are known to play a role in tissue homeostasis, e.g. by 
maintaining tolerance to renal antigens or by clearing apoptotic cells (19). The absence of 
GFP cells in PT profiles excludes the replacement of damaged tubular cells by BM-derived 
cells in this model. 
 The engraftment of BM-derived mononuclear phagocytes resulted in a partial rescue 
of ClC-5 and megalin expression in the Clcn5
Y/-
 kidneys, with proper expression of the 
receptor and the endosomal transporter in the apical membrane and sub-apical domain of PT 
cells. This observation provides a mechanistic basis for the rescue of endocytosis observed in 
Clcn5
Y/-
 mice. We showed previously that there is no transcriptional defect of megalin in 
Clcn5
Y/-
 kidneys. Instead, the deletion of ClC-5 causes a trafficking defect reflected by the 
loss of megalin from the brush border (9). Thus, the transfer of a certain amount of functional 
ClC-5 and/or megalin (protein or mRNA) to PT cells could be sufficient to rescue megalin 
expression and receptor-mediated endocytosis (and potentially other apical transport systems 
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such as NaPi-IIa). Peritoneal macrophages are known to express ClC-5 (24), as do the 
differentiated BM-derived cells used here - suggesting that the transplanted BM cells express 
ClC-5 when acquiring their tissue-resident phenotype. This might explain the significant 
increase of Clcn5 mRNA and ClC-5 protein expression in PT cells of Clcn5
Y/-
 mice 
transplanted with Clcn5
Y/+
 BM compared to controls. The possibility that low-level ClC-5 
expression may rescue megalin targeting in PT cells and sustain some level of endocytic 
uptake is supported by the inverse correlation between rescued Clcn5 gene expression in the 
Clcn5
Y/-
 kidneys and the level of LMW proteinuria. The fact that the decrease in urinary 
CC16 does not exactly match the rescue of megalin and ClC-5 protein expression is not really 
surprising when considering the complexity of receptor-mediated endocytosis, with multiple 
steps including - but not limited to - those involving megalin and ClC-5. These observations 
made in vivo are supported by the in vitro system based on the co-culture of primary PT cells 
derived from Clcn5
Y/-
 kidneys and GFP+ BM cells obtained from Clcn5 WT and KO mice. 
The primary cultures of mouse PT cells (mPTCs) have been shown to retain their 
differentiation and the PT features observed in vivo (25,26), whereas prior exposure of the 
BM cells to GM-CSF resulted in their differentiation into functional mononuclear phagocytes 
expressing ClC-5 and megalin. The subsequent 2-day co-culture confirmed the rescue of 
megalin and ClC-5 expression, mirrored by the partial recovery of endocytosis.  
 What could be the mechanism driving the rescue of ClC-5 and megalin expression in 
the Clcn5
Y/-
 PT cells, resulting in the improved phenotype in vivo and in vitro? The close 
proximity between transplanted BM-derived cells and PT cells as well as the rescue of ClC-5 
and megalin expression in the latter support the hypothesis of a cell-to-cell transfer of 
material between the two cell types. We evidenced a higher recruitment of BM-derived cells 
into the Clcn5
Y/-
 kidneys compared to the Clcn5
Y/+
 controls, with transplanted cells 
surrounding PT profiles and establishing close contacts with PT cells. Chronic injury is a pre-
requisite to stimulate the long-term engraftment of BM-derived cells to the kidneys (27), 
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suggesting that a homing factor may attract transplanted cells close to diseased PT cells. In 
general, intercellular communication can be achieved by paracrine and endocrine signaling, 
transfer of extracellular vesicles, and cell-to-cell contact mechanisms including tunneling 
nanotubes (28,29). The tunneling nanotubes are dynamic, F-actin based tubular connections 
that allow communication between relatively distant cells. They operate between various cell 
types, with a heterogeneous structure reflecting distinct functions. In particular, relatively 
thick (diameter >0.7 M) tunneling nanotubes containing microtubules have been described 
in macrophages and other cell types (30), with an ability to transfer several types of cargo 
including vesicles derived from endosomes, plasma membrane components, as well as 
cytoplasmic molecules (29). Recent co-culture experiments showed that tunneling nanotubes 
produced by macrophages and extending into fibroblasts mediate a vesicular exchange able to 
correct the lysosomal defect in cystinosis (14). Such macrophage-derived tubular extensions 
have also been evidenced in vivo, penetrating the tubular basement membrane and delivering 
cystinosin-containing lysosomes into PT cells (14).  
 We observed similar nanotubular extensions between GFP+ BM-derived cells closely 
surrounding Clcn5
Y/-
 PT cells in vivo and in vitro, with multiple contact points between the 
transplanted cells and PT cells (Fig. 8). It must be noted that the differentiated BM-derived 
cells expressed M-sec, a central factor in the induction of plasma membrane protrusion 
during tunnelling nanotube formation (31), as well as myosin Va, a motor protein that 
facilitates organelle transport in tunnelling nanotubes (28). Conversely, no rescue of ClC-5 
and megalin, and no improvement of albumin endocytosis were observed when the cells are 
separated by a transwell insert system or when the formation of tunneling nanotubes is 
prevented by treatment with Latrunculin B - an actin-depolymerizing drug known to inhibit 
the development of cell-to-cell connections (30). Taken together, these results suggest that 
the establishment of a direct contact between transplanted mononuclear phagocytes and PT 
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cells, via tunnelling nanotubes, may enable the transfer of ClC-5 mRNA or protein into 
Clcn5
Y/-
 PT cells, partially rescuing the PT phenotype. 
 In summary, these data provide the first demonstration that BM transplantation may 
rescue the epithelial phenotype due to an inherited endosomal defect, through direct contacts 
between transplanted BM-derived cells and diseased proximal tubular cells.  
 
 
  
106 
 
MATERIAL AND METHODS  
Clcn5 mouse model of Dent disease. Clcn5 mice were generated by deletion of exon VI of 
Clcn5 and have been extensively characterized as a faithful model of Dent disease (9,16). 
ClC-5 KO males (Clcn5
Y/-
) and WT littermate controls (Clcn5
Y/+
) on pure C57BL/6 
background were used for experiments. BM donors expressed an enhanced GFP under the 
direction of the human ubiquitin C promotor (UBC-GFP), leading to ubiquitous GFP 
expression in all cells (The Jackson Laboratory, Bar Harbor, ME, USA). All BM donor mice 
were on C57BL/6 background and only males were used. Mice were bred and housed under 
specific pathogen-free conditions at University of Zurich, and all animal experiments were 
performed according to protocols approved by the local legal authority (Veterinary office, 
Canton of Zürich, Switzerland). 
 
Bone marrow transplantation. The Clcn5 littermates were lethally irradiated (900cGy) with 
a Cs source and reconstituted approximately 6 h later by tail vein injection of 10x 10
6 
unfractionated BM cells suspended in Media 199 containing 10 mM HEPES, 10 µg/ml 
DNAse and 4 µg/ml Gentamycin.  BM cells were either isolated from UBC-GFP or Clcn5
Y/-
 
donors aged 8-14 weeks. Recipients were randomly distributed among treatment groups and 
transplanted at the age of 10 weeks. Peripheral blood multilineage chimerism was measured 
by FACS at the time of harvest. Cells were stained for CD4, CD8, CD11b and B220 and 
acquired at FACS Canto II or LSRII Fortessa. 
 
Urine and plasma collections. Urine samples were collected overnight in metabolic cages 
with ad libitum access to food and drinking water one week prior BM transplantation and 10 
and 16 weeks after transplantation. Urinary calcium, glucose, and creatinine were measured 
with a Synchron CX3 Delta System (Beckman Coulter, Nyon, Switzerland) and urinary 
CC16 was measured by an enzyme-linked immunosorbent assay kit (Biomatik, Wilmington, 
DE, USA). 
 
Kidney sampling. Mice were anesthetized using an isoflurane vaporizer and perfused through 
the right ventricle with a 0.9% NaCl solution containing heparin (5000 U/ml), 1% Procain-
HCL (Lidocain) and 16% CaCl2. Then, the left kidney was clamped and the right kidney 
fixed by infusion of 3% PFA dissolved in 0.1M Na-cacodylate. One half of the unfixed 
kidney was used for protein isolation and the other half for RT-qPCR analysis. The fixed 
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kidney was kept for 1h in 3% PFA on ice, then in 1% PFA overnight. After washing in PBS 
and soaking in 30% sucrose, the kidneys were embedded in Tissue-Tek OCT medium (VWR, 
Radnor, PA, USA). 
 
Isolation and primary cultures of mouse PT cells. Primary cultures of mouse PT cells 
(mPTCs) were prepared from gender-matched Clcn5
Y/-
 mice transplanted with KO-BM cells 
or GFP-BM cells, and from Clcn5
Y/+
 mice transplanted with GFP+ BM cells as described 
previously (20,25,26). Confluent monolayers of mPTCs expanded from the tubular fragments 
after 6–7 days. All experiments were performed on non-passaged, confluent monolayers 
grown on collagen-coated filters. 
 
Cultures of BM cells and co-culture experiments. BM cells were isolated from femurs of 
GFP-expressing Clcn5
Y/+
 mice and of Clcn5
Y/-
 mice and were differentiated in the presence of 
the granulocyte-macrophage colony-stimulating factor (GM-CSF, 30ng/mL) for 7 days, as 
previously described (32).  
For contact co-culture assays, 1 × 10
5
 mPTCs were plated with 1 × 10
5
 GFP+ or KO BM-
derived cells in 10 cm culture dishes. Cells were incubated for 2 days at 37°C, harvested 
using trypsin, pelleted and resuspended in PBS with 2% FBS.  
For the Latrunculin B assay, 1 × 10
5
 mPTCs were seeded with 1 × 10
5
 GFP+ or KO BM-
derived cells in 24 well-plates (Corning Life Sciences) in presence of 5 μM of Latrunculin B 
(Sigma, St. Louis, MO, USA) for 2 days at 37°C as previously described (33). The albumin 
endocytic assay was performed (see below) and the cells were further processed for 
immunofluorescence staining. 
For the transwell co-culture assay, mPTCs were seeded onto top of collagen-coated PTFE 
filter membranes (0.33 cm
2
, pore size 0.4 µm, Transwell-COL™, Costar™, Corning Life 
Sciences) and GFP+ BM-derived cells were plated on the basolateral side of collagen coated 
24-well plates  for 2 days at 37°C. The albumin endocytic assay was then performed on the 
mPTCs and the cells were processed for immunofluorescence staining. 
 
Albumin endocytic uptake. The endocytosis assay was performed on monolayers of mPTCs 
as described previously (26). Briefly, monolayers of mPTCs were incubated with either 0.5 
mg/mL Alexa 488- BSA or Alexa 647-BSA (both from Thermo Fischer Scientific, Watham, 
MA, USA) for 15 min at 37°C. After the incubation, primary cultures were washed  and fixed 
in 4% PFA and and counterstained with 10 M Hoechst 33342 (H1399; Thermo Fischer 
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Scientific). The slides were mounted in Prolong Gold Anti-fade reagent (P36930; Thermo 
Fisher Scientific), acquired on Leica SP5 confocal laser scanning microscope (Leica, 
Heerbrugg, Switzerland). Quantitative image analysis was performed by selecting randomly 
2-4 fields containing ~ 50 cells, using the same setting parameters (i.e. laser power, offset 
gain and detector amplification below pixel saturation). The number of albumin-positive 
vesicles was performed using AnalySIS software (Soft Imaging Systems GmbH, Muenster, 
Germany). 
 
Quantitative real-time PCR. Total RNA was extracted from kidney using the Aurum™ Total 
RNA Fatty and Fibrous Tissue Kit (Bio-Rad, Hercules, CA, USA) according to 
manufacturer’s protocol. DNAse I treatment was performed to eliminate genomic DNA 
contamination. 1 μg of RNA was used to perform the reverse transcriptase reaction with 
iScript™ cDNA Synthesis Kit (Bio-Rad). Changes in target gene mRNA levels were 
determined by relative RT-qPCR with a CFX96™ Real-Time PCR Detection System (Bio-
Rad), using iQ™ SYBR Green Supermix (Bio-Rad). RT-qPCR analyses were performed in 
duplicate. Specific primers were designed using Primer3 (http://simgene.com/Primer3) 
(Suppl. Table 1). PCR conditions were 95°C for 3 min followed by 40 cycles of 15 sec at 
95°C, 30 sec at 60°C.The PCR products were sequenced with the BigDye terminator kit 
(Perkin Elmer Applied Biosystems, Thermo Fischer Scientific). The efficiency of each set of 
primers was determined by dilution curves (Suppl. Table 1). The relative changes in target 
over Gapdh mRNAs was calculated using 2
Δct
 formula. 
 
Antibodies. The following antibodies were used: rabbit anti-GFP ( Thermo Fischer 
Scientific), goat anti-GFP (Sicgen Research and Development in Biotechnology, Carcavelos, 
Portugal),  rabbit anti-AQP1 (Millipore, Temecula, California, USA), rabbit anti-Napi-IIa 
(gift from C.A. Wagner, University of Zurich), sheep anti-megalin (a gift from Dr. P. 
Verroust and Dr. R. Kozyraki, Paris), rabbit anti-ClC-5 (gift from J. Loffing, University of 
Zurich), rat anti-F4/80 (ABD Serotec Bio-Rad, Puchheim, Germany), hamster anti-CD11c 
(Bio-Rad), rat anti-CD45 (Bio-Rad),  rabit anti--SMA (Abcam, Cambridge, UK), mouse 
anti--actin (Sigma-Aldrich), rabbit anti-Rab5 (Abcam), mouse anti--tubulin (Sigma-
Aldrich), rabbit anti-collagen IV antibody (Abcam, Cambridge, UK). Secondary antibodies 
were labelled with Alexa488, Alexa633 or Dylight649. 
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Immunofluorescence and confocal microscopy. Six-μm mouse kidney sections were 
quenched with 50 mM NH4Cl, blocked with 0.5% BSA in PBS Ca/Mg (D1283; Sigma-
Aldrich) for 30 min and stained with primary antibodies diluted in blocking buffer overnight 
at 4°C. After two washes in 0.1% Tween 20 (v/v in PBS), the slides were incubated with 
corresponding fluorophore-conjugated secondary antibodies (Invitrogen, Thermo Fischer 
Scientific) diluted in blocking buffer at room temperature for 1 h and counterstained with 10 
M Hoechst 33342 (H1399; Thermo Fischer Scientific). The slides were mounted in Prolong 
Gold Anti-fade reagent (P36930; Thermo Fisher Scientific), acquired on Leica SP5 confocal 
laser scanning microscope. Quantitative image analysis was performed by selecting randomly 
3 visual fields per each slide that included at least 2-4 PT sections, using the same setting 
parameters. The number of GFP-positive cells per mm
2
 was quantified by means of the 
Volocity software (I40250; PerkinElmer, Waltham, MA, USA) and the distance of GFP-
positive cells from PT cells (megalin-positive brush border membrane) was measured using 
the Huygens software (Scientific Volume Imaging, Hilversum, The Netherlands).  
The cells were fixed for 10 min in 4% paraformaldehyde (Sigma-Aldrich,) in PBS, 
permeabilized and quenched for 30 min in blocking buffer (50 mM NH4Cl, 0.1% (w/v) 
saponin, 3% (w/v) BSA in PBS). The cells were then incubated 2 h with the primary 
antibody, washed six times in PBS, incubated for 1 h with the Alexa-labelled secondary 
antibody and mounted on Vectashield covered coverslips (Vector Laboratories, Burlingame, 
CA, USA) to be acquired on Leica SP5 confocal laser scanning microscope (Leica). 
 
Immunoblotting. Proteins were extracted from frozen kidneys lysed in RIPA buffer (Sigma) 
containing protease inhibitors (Roche Diagnostics, Mannheim, Germany), followed by a brief 
sonication and centrifugation at 16’000xg for 1min at 4°C. Protein concentration was 
determined using the Pierce BCA protein assay (Thermo Fischer Scientific). Immunoblotting 
and quantification of the signals were performed as described previously (25,26). 
 
Statistics. The effect of BM transplantation was analyzed by comparing parameters by 
Kruskal Wallis, Mann Whithney or Wilcoxon signed rank tests, as indicated. Differences 
between unpaired groups were assessed using Mann-Whitney test, and correlation between 
Clcn5 mRNA expression and urinary loss of CC16 were assessed with GraphPad Prism. 
P<0.05 was considered significant, *P<0.05; **P<0.01; ***P<0.001; NS, not significant. 
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Table 1. Urine and plasma parameters at baseline and in transplanted Clcn5
Y/-
 and Clcn5
Y/+ 
mice. 
 
Baseline Clcn5Y/- Clcn5Y/+ P value  
 (Negative controls) 
(n = 8-10) 
 (Treated) 
(n = 13-15) 
 (Positive controls) 
(n = 6-9) 
Clcn5
Y/-
 
vs 
Clcn5
Y/+
 
Diuresis (ml/12h) 1.98 ± 0.26
*
 2.04 ± 0.21
*
 1.20 ± 0.19 <0.01 
U CC16 (mg/g creat) 62.3 ± 4.3 66.7 ± 5.3 ND ND 
U glucose (mg/12h) 1.21 ± 0.15
*
 1.44 ± 0.14
*
 0.49 ± 0.06 <0.0001 
U Ca
2+
 (mg/g creat) 216 ± 29
*
 196 ± 12
*
 83 ± 5 <0.0001 
BUN (mg/dl) 24.5 ± 1.2 24.3 ± 1.1 25.1 ± 1.7 NS 
 
Week 10 Clcn5
Y/-
 + KO-BM 
(Negative controls) 
Clcn5
Y/-
 + GFP-BM 
(Treated) 
Clcn5
Y/+
 + GFP-
BM 
(Positive controls) 
P value 
Diuresis (ml/12h) 4.07 ± 0.64
*
 4.04 ± 0.84
*
 1.31 ± 0.19 0.0001 
U CC16 (mg/g creat) 66.6 ± 5.5 53.9 ± 6.0 ND 0.087 
U glucose (mg/12h) 1.07 ± 0.18
*
 1.07 ± 0.16
*
 0.40 ± 0.08 0.0006 
U Ca
2+
 (mg/g creat) 160 ± 26 132 ± 13 111 ± 36 0.13 
BUN (mg/dl) 26.8 ± 1.7 25.0 ± 1.3 24.1 ± 1.2 0.54 
 
Week 16 Clcn5
Y/-
 + KO-BM 
(Negative controls) 
Clcn5
Y/-
 + GFP-BM 
(Treated) 
Clcn5
Y/+
 + GFP-
BM 
(Positive controls) 
P value 
Diuresis (ml/12h) 6.04 ± 1.52
*
 3.36 ± 0.92
*
 1.03 ± 0.24 0.0002 
U CC16 (mg/g creat) 71.2 ± 3.5 46.9 ± 5.1
§
 ND 0.0031 
U glucose (mg/12h) 0.87 ± 0.10
*
 0.81 ± 0.12
*
 0.36 ± 0.07 0.0023 
U Ca
2+
 (mg/g creat) 146 ± 21
*
 131 ± 10
*
 99 ± 31 0.0126 
BUN (mg/dl) 24.6 ± 1.4 24.7 ± 0.9 23.4 ± 1.5 0.70 
U, urine; CC16, Clara cell protein of 16 kDa; P, plasma; ND, not detected; NS not significant 
*  P<0.05 vs Clcn5
Y/+
 + GFP-BM ; §  P<0.05 vs Clcn5
Y/-
 + KO-BM 
Baseline parameters: Mann Whithney Test (Clcn5
Y/-
 versus Clcn5
Y/+
); Week 10 and week 16: One way anova non 
parametric (Kruskal Wallis Test) for all parameters except U CC16 (Mann Whithney Test) 
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Figure 1: Study design and peripheral blood chimerism. 
(A) Experimental setup of the study: Clcn5
Y/-
 and Clcn5
Y/+
 littermates were transplanted at the age of 10 weeks with either wild-type (WT, Clcn5
Y/+
) GFP+ or knock-
out (KO, Clcn5
Y/-
) BM cells. Baseline blood sampling and urine collection (overnight) were performed the week before BM transplantation as well as 10 weeks and 
16 weeks after BM transplantation. (B) Lineage-specific peripheral blood chimerism was measured by FACS analysis of GFP+ cells at time of kidney harvest. A 
nearly 100% myeloid and B cell chimerism was observed. 
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Figure 2: Evolution of urinary parameters after BM transplantation in Clcn5
Y/-
 mice. 
Evolution (baseline to week 16) of urinary parameters (diuresis, urinary excretion of the LMW protein CC16, glycosuria, calciuria) in Clcn5
Y/-
 mice transplanted 
with either WT (Clcn5
Y/+
) GFP+ or KO (Clcn5
Y/-
) BM cells. The Clcn5
Y/- 
mice transplanted with WT BM cells showed no significant change in diuresis and a 
significant reduction in the urinary excretion of CC16, glycosuria and calciuria as compared with increased or stable values in Clcn5
Y/- 
mice transplanted with KO 
BM cells. Differences in urinary parameters from baseline to week 16 were assessed with Wilcoxon signed rank test. *P<0.05; **P<0.01; NS, not significant. 
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Figure 3: Engraftment of transplanted BM cells in the Clcn5 kidneys. 
(A) Western blot for GFP protein expression in kidney lysates of transplanted ClCn5
Y/+
 and ClCn5
Y/-
 mice. The lower panels show the densitometry of immunoblot 
signals and the real-time qPCR analysis of Gfp mRNA expression in the Clcn5
Y/+
 and Clcn5
Y/-
 transplanted kidneys. The engraftment of BM-derived cells is 
significantly higher in the Clcn5
Y/-
 transplanted kidneys. Statistical differences were assessed using the Mann-Whitney test. *P<0.05 (B) Confocal microscopy 
images showing GFP expression in kidneys of Clcn5
Y/+
 and Clcn5
Y/-
 mice that were transplanted with WT, GFP+ BM cells or KO BM cells. The graph gives the 
quantification of GFP-BM cells per mm
2
. *P<0.05; ***P<0.001. 
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Figure 4: Recovery of megalin and ClC-5 expression in Clcn5
Y/-
 kidneys of BM-transplanted mice. 
(A) Western blot for megalin, ClC-5, GFP, AQP1 and Rab5 in kidney lysates and quantification of optical density for megalin and ClC-5 in the lower panel. Bone 
marrow transplantation did not induce unspecific effects on protein expression in Clcn5
Y/+
 and Clcn5
Y/-
 kidneys. A significant rescue of megalin and ClC-5 was detected 
in Clcn5
Y/-
 kidneys of mice transplanted with WT GFP+ BM cells. n = 4 animals per conditions. ***P<0.001 vs Clcn5
Y/+
, **P<0.01 vs Clcn5
Y/-
 transplanted with KO-
BM cells, Mann-Whitney test.  (B) Confocal microscopy images showing staining for GFP (green), megalin (red, left panels) and ClC-5 (red, right panels) in Clcn5
Y/+ 
and Clcn5
Y/-
 mice transplanted with WT GFP+ BM cells. Contrasting with the lack of ClC-5 and megalin staining in Clcn5
Y/-
 kidneys of mice transplanted with KO BM 
cells, an appreciable rescue of megalin in the brush border and ClC-5 in the apical region was observed in Clcn5
Y/-
 kidneys of mice transplanted with WT BM cells. (C) 
Inverse correlation between the expression of Clcn5 mRNA in Clcn5
Y/-
 kidneys of mice transplanted with WT BM and the levels of urinary CC16. Mann-Whitney test 
was used to assess difference between treatment groups, and correlation represents a linear regression-model with 95% CI. There was no Clcn5 mRNA signal in 
ClCn5
Y/-
 kidneys of mice transplanted with KO BM. 
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Figure 5: Characterization and distribution of BM-derived cells in Clcn5 kidneys.  
(A) Confocal microscopy images showing staining for megalin (red) and GFP (green) in kidney sections of Clcn5
Y/-
 (left panel) and Clcn5
Y/+
 (right panel) mice 
transplanted with GFP+ BM cells. Bottom panel: average distance of GFP+ BM cells in relation to (megalin-positive) PT cells in transplanted kidneys. In Clcn5
Y/-
 
kidneys, a higher number of transplanted GFP+ cells surround the PT profiles, and they are closer to PT cells, compared to the Clcn5
Y/+
 kidneys in which less GFP+ 
cells are engrafted. **P<0.01, Mann-Withney test. (B) Staining for GFP (green), Dapi (blue), mononuclear phagocyte markers CD45, CD11c, F4/80 (red) and the 
fibroblast m -SMA in kidneys of Clcn5
Y/-
 mice transplanted with GFP+ BM cells. The GFP+ BM-derived cells co-stain with CD45, CD11c and F4/80, 
identifying these cells as monoculear phagocytes There is no overlap between the GFP cells and the fibroblast marker α-SMA. 
 
120 
 
 
  
Figure 6: Setup of co-culture experiments and characterization of BM cells. 
 (A) Setup of co-culture experiments: primary cultures of PT cells (mPTCs) were obtained from microdissected PT segments of kidneys of Clcn5
Y/+
 and Clcn5
Y/-
 mice 
and grown for 7 days. These cells were then co-cultivated for 2 days with BM-derived DCs/macrophages (BM-DC/M), that were generated by stimulating either WT 
(GFP+) or KO BM cells for 7 days with granulocyte-macrophage colony-stimulating factor (GM-CSF), resulting in a mixed population of adherent phagocytic cells. (B) 
Staining for GFP (green), Dapi (blue), and the mononuclear phagocyte markers CD45 (red) and F4/80 (red) in co-cultures of BM-DC/M cells with mPTCs derived 
from Clcn5
Y/-
 mice. (C) Progressive upregulation of mRNA encoding for ClC-5 (Clcn5), for the macrophage markers F4/80 (Adgre1), CD45 (Ptprc), CD11c (Itgax), and 
for the tunnelling nanotube markers myosin Va (Myo5a) and Msec (Tnfaip2) was observed during the differentiation process of freshly isolated BM cells into BM-
DC/M. **p<0.01 vs d0; ***p<0.001 vs d0, Mann-Withney test. 
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Figure 7: Co-cultures rescue megalin, ClC-5 and endocytosis in Clcn5
Y/-
 PT cells.  
(A) Upper panel: Staining for GFP (green), Dapi (blue), AQP1 (red), megalin (red), and ClC-5 (red) in mPTCs derived from Clcn5
Y/+
 and Clcn5
Y/-
 kidneys, that were 
co-cultured with WT GFP+ or KO BM-derived BM-DC/MΦ. Co-culture with WT GFP+ BM-derived cells rescues the expression of ClC-5 and megalin in the Clcn5Y/- 
mPTCs, whereas no signal is observed in Clcn5
Y/-
 mPTCs co-cultured with KO BM-derived BM-DC/MΦ. Lower panel. Western blot for megalin and ClC-5 in cell 
lysates of mPTCs derived from ClCn5
Y/+
 and ClCn5
Y/-
 mice, that were co-cultured with WT GFP+ BM-derived cells from ClCn5
Y/+
 (WT) or BM-derived cells from 
Clcn5
Y/-
 (KO) mice. (B) Upper panel. Uptake of Alexa 647-conjugated BSA (red channel) in mPTCs derived from Clcn5
Y/+
 and Clcn5
Y/-
 kidneys, that were co-cultured 
with WT GFP+ BM-DC/MΦ or KO BM-DC/MΦ. A rescue of the endocytic uptake of Alexa 647-BSA is observed in Clcn5Y/- mPTCs co-cultured with WT GFP+ 
BM-derived cells. Lower panel: Quantification of Alexa 647-BSA-positive vesicles per nucleus. **P<0.01 vs Clcn5
Y/+
. 
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Figure 8:  Nanotubes mediate interactions between BM-derived cells and PT cells. 
(A) Panels a-d: Kidney sections of Clcn5
Y/-
 mice transplanted with GFP+ BMcells showing staining for GFP (green), Dapi (blue) and megalin or collagen IV (red). 
Arrowheads indicate the nanotubular prolongations of the engrafted GFP+ cells contouring the basal membrane of a PT (panel b) and penetrating to collagen IV-
positive basement membrane to establish a direct contact with PT cells (panels c and d). The asterisk indicates the lumen of the PT.  
Panels e-f: Staining of GFP (green), tubulin (red) and Dapi (blue) in mPTCs derived from Clcn5
Y/-
 mice co-cultivated with GFP+ BM BM-DC/M cells. Multiple 
tunneling nanotubes positive for tubulin are identifed, establishing connections between BM-derived cells and mPTCs. 
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Figure 8:  Nanotubes mediate interactions between BM-derived cells and PT cells. 
(B) Uptake of Alexa 647-BSA (red channel) in co-cultures of mPTCs derived from Clcn5
Y/+
 and Clcn5
Y/- 
mice with GFP+ BM-derived cells, in presence of the actin 
depolymerizing agent Latrunculin B or vehicle (Control). Incubation with Latrunculin B inhibits the formation of nanotubes from the GFP+ BM-DC/M, with a lack of 
rescue of the endocytic uptake of Alexa-BSA in Clcn5
Y/- 
mPTCs. *P<0.05 vs control (Clcn5
Y/+
+GFP-BM without Latrunculin), §P<0.05 vs Clcn5
Y/-
+GFP-BM without 
Latrunculin). (C) Western blot for megalin and ClC-5 in lysates of mPTCs derived from Clcn5
Y/+
 and Clcn5
Y/-
 mice, that were co-cultured with WT GFP+ or KO BM-
derived cells in the presence or not of Latrunculin B and quantification of optical densities. Treatment with Latrunculin B almost abolished the rescue of megalin and 
ClC-5 in co-cultures of Clcn5
Y/-
 mPTCs and WT BM-derived cells. Representative of two experiments. **P<0.01 vs control. (D) Uptake of Alexa 647-BSA in mPTCs 
derived from Clcn5
Y/+
 and Clcn5
Y/- 
kidneys seeded onto top of collagen-coated transwell filters, with either WT or KO BM-DC/Mat the basolateral side. 
Quantification of BSA-positive vesicles per cell reveals no rescue of the endocytic uptake in Clcn5
Y/+
 mPTCs cultured with WT BM-derived cells in the basal 
compartment of the transwell filters. **P<0.01 vs Clcn5
Y/+
. 
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ABSTRACT 
Dent disease 2 is a rare X-linked disease characterized by congenital cataracts, central hypotonia, 
intellectual disability and renal Fanconi syndrome. This disease is caused by mutations in OCRL 
which encode for an inositol polyphosphate 5-phosphatase (OCRL) that regulates intracellular 
trafficking by acting on phosphoinositides, constituents of cell membranes. Loss of function of 
OCRL results in defective receptor-mediated endocytosis and severe proximal tubule (PT) 
dysfunction. Bone marrow transplantation has recently been shown to preserve kidney function in 
cystinosis, a lysosomal storage disease causing proximal tubule dysfunction. Here we test the 
effects of bone marrow transplantation in Ocrl
Y/-
 mice, faithful model for Dent disease 2. We 
established a co-culture system based on primary cultures of mouse proximal tubular cells which 
were then co-cultivated for 2 days with BM-derived DCs/macrophages. Co-culture of Ocrl
Y/-
 PT 
cells with wild-type bone marrow–derived cells rescued megalin expression resulting in 
improved endocytosis. Bone marrow–derived cells established contacts with PT cells through 
nanotubular extensions in a dynamic manner and exchanged materials. No rescue was found 
when the formation of the tunneling nanotubes was prevented by actin depolymerization or when 
cells were physically separated by transwell inserts.  In summary, bone marrow transplantation 
may rescue the epithelial phenotype due to an inherited endosomal defect through direct contact 
between transplanted BM-derived cells and diseased proximal tubular cells. 
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Cocultures of bone marrow (BM)-derived cells with OcrlY/- proximal tubule cells rescue receptor-mediated endocytosis and Megalin expression through tunneling nanotubes 
formation (TNTs)  
mPTCs derived from Ocrl kidneys were cocultured with WT GFP (green) or OcrlY/- derived BM-DC/ MΦ. (A) Cocultured cells were loaded with Al647-BSA (red, 100 μg ml−1 for 15 
min at 37 °C), fixed and analyzed by confocal microscopy. Quantification of  the number of Al633-BSA+ structures (n 400-450 cells pooled from three mouse kidneys per condition; 
each point representing the number of BSA+ structures in a cell). Plotted data represent mean ± SEM. Two-tailed unpaired Student’s t-test, ***P < 0.001 relative to OcrlY/+ mPTCs. 
Scale bars are 10 μm. (B) Representative confocal micrographs of the number of Megalin+ (red) structures in cocultured cells Insets: high magnification of LRP2/ GFP+ structures. (C-
D) Cocultured cells were loaded with Sir-Actin (red, 100nM) and immediately imaged. (C) Representative confocal micrographs of tunneling nanotubes structure (green, TNTs) 
extended from BM derived cells to proximal tubule cells. (D) Snapshots selected from a time-lapse video at the indicated time to visualize TNTs formation and transfer of GFP+ 
vesicles from BM derived cells to proximal tubule cells. Cocultured cells were imaged every 15 seconds for 45 minutes. Nuclei counterstained with DAPI (blue). (E) mRNA levels for 
GFP (green fluorescent protein), macrophage marker F4/80 (Adgre1), tunneling nanotube markers Plekstrin (Plek) and myosin Va (MyoVa) and Ocrl (Inositol Polyphosphate-5-
Phosphatase) and Inpp5b (Inositol polyphosphate-5-phosphatase B) during the differentiation of isolated BM cells into BM-DC/MΦ were analyzed by real-time qPCR.  Gene target 
expression normalized to Gapdh (n = 3 mice per group). Two-tailed unpaired Student’s t-test, **P < 0.01, ***P < 0.001 relative to day 0 
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IV- Discussion 
The epithelial cells lining the proximal tubules (PT) of the kidney ensure ~80% of the total 
metabolic clearance of small proteins and peptides including  LMW proteins that would 
otherwise be lost in the urine, thus playing an important role in hormone and vitamin homeostasis 
(Christensen and Birn 2002). These substances are reabsorbed by receptor-mediated endocytosis 
triggered by their interaction with multi-ligand receptors, megalin and cubilin, followed by 
internalization, delivery to endosomes and further to lysosomes for processing and degradation. 
Genetic diseases involving the receptors (e.g. Imerslund-Gräsbeck syndrome) or the 
endolysosomal pathway (e.g. Dent disease or cystinosis) lead to massive urinary losses of solutes 
and LMW proteins, often complicated by multi-systemic complications and progression to end-
organ damage (Devuyst and Luciani 2015).  
          The intertwining of endo-lysosomal vesicle trafficking requires a delicate spatiotemporal 
regulation of membrane dynamics and the capacity to adapt to changes in flow rates. It has long 
been hypothesized that the primary cilium, a microtubule-based organelle that is expressed on 
most eukaryotic cells, sense the urinary flow triggering an intracellular influx of calcium ions 
thus allowing the regulation of numerous cellular process (Nauli et al, 2003). Another interesting 
property of the cilium is its ability to adjust its morphology in response to environmental 
conditions, depending on the strength of the signal that they detect (Reiter and Leroux 2017). A 
growing number of studies show that the primary cilium regulates cell functions including 
endocytosis (Satir, Pedersen et al. 2010). Indeed, the ciliary pocket at the basis of the primary 
cilium is a privileged site of formation of clathrin-coated pits and vesicles (Molla-Herman et al 
2010). Since the ciliary membrane is in continuum with the plasma membrane, this region could 
contribute to the endocytic activity and formation of autophagosome precursors at the apical pole 
of the the cells (Pampliega and Cuervo 2016). Furthermore, primary cilia have been shown to 
mediate the stimulation of apical endocytosis in response to flow-induced fluid shear stress in 
immortalized PT cells (OK, LLCPK) (Molla-Herman, Ghossoub et al. 2010, Raghavan, Rbaibi et 
al. 2014, Long, Shipman et al. 2017). These findings promote the hypothesis that alterations of 
the primary cilia could affect the regulation of apical endocytosis in PT cells (Raghavan & 
Weisz, 2016). On the other hand, the primary cilium function has recently been linked to 
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autophagy, a catabolic process that delivers cytoplasmic components and organelles to lysosomes 
for digestion (Settembre et al. 2013). Considering that kidney cells requires an efficient 
autophagy-mediated clearance system to cope with the  high reabsorptive function of the PTs, 
this homeostatic mechanism is of particular importance and has been shown to protect against 
acute tubular injury (Kimura, Takabatake et al. 2011). The functional interaction between the 
primary cilium and autophagy is complex, reflecting mutual regulation (Pampliega and Cuervo 
2016). Proper ciliogenesis and intact primary cilium function are required for autophagy 
activation, but autophagy also regulates primary cilia through the specific degradation of ciliary 
proteins, such as the intraflagellar transport system protein IFT20, that promote ciliogenesis 
(Pampliega, Orhon et al. 2013).  
Using genetic models of PKD (Cy/+ rat) and (Pkd1 inducible knock-out mouse) as a 
hallmark of cilia dysfunction, our studies substantiate a link between primary cilium and 
receptor-mediated endocytosis in PTs. Indeed, we evidenced a selective LMW proteinuria at an 
early stage of the disease and in absence of renal failure. One major limitation to study the role of 
primary cilium in the kidney is the availability of appropriate cellular models. Therefore, we 
developed a primary proximal tubular cell culture system from rat kidneys based on our expertise 
and these cells recapitulate not only all the features of the epithelial cells of the PTs, but possess 
the ability to form cilia (Terryn, Jouret et al. 2007). Using this system, we showed that the 
endocytosis impairment was associated to severe morphological and functional defects of the 
primary cilium becoming unresponsive to flow. The inbred Cy/+ rat is a well-established model 
for inherited PKD characterized by the development of cortical cysts and a slow progression to 
ESRD (Schafer et al, 1994). These cysts are caused missense mutation in ANKS6 encoding for 
SamCystin which contains ankyrin repeats and a sterile alpha motif (SAM). ANKS6 mutations 
have been identified in families affected by nephronophthisis. ANKS6 was demonstrated to 
mediate interaction between NEK8, INVS and NPHP3 in the Inv compartment of the primary 
cilium (Hoff, Halbritter et al. 2013, Nakajima, Kiyonari et al. 2018).  
The endocytosis and ciliary defects reported in the Cy/+ rats and the Pkd1 mouse were 
associated with a specific marked accumulation of IFT20, a key member of intraflagellar traffic 
complexes ensuring the shuttle of essential ciliary proteins from the Golgi apparatus to the basal 
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body. Considering the fundamental role of autophagy in regulating the bioavailability of essential 
components of the ciliogenesis, we investigated the autophagic process and we observed an 
accumulation of p62 and LC3, two substrates normally degraded within the autolysosomes, 
suggesting an abnormal autophagic flux due to defects in the late phase of autophagy. The 
question arising from these findings is how primary dysfunctions of the cilium, namely ANKS6 
or PC1 defects, affect the autophagic function. We hypothesized a putative role of these proteins 
in the delivery of cathepsins from Golgi to the lysosomes or in the maturations of these 
hydrolases in the lysosomal compartment. We evidenced a defective lysosomal proteolysis in 
Cy/+ and Pkd1 derived PT cells associated to a lack of active cathepsins in the lysosomes 
suggesting a defective maturation in spite of a normal delivery of cathepsins. Taken together, our 
data support the concept that the autophagy impairment, caused by a defective lysosomal 
function, leads to the accumulation of the ciliary protein IFT20 ultimately resulting in an increase 
of the ciliary length contributing to the endocytosis defects. These findings are reminiscent of the 
cellular changes observed in a monoclonal light chain–associated renal Fanconi Syndrome and 
cystinosis (Festa et al, 2018; Luciani et al, 2016). Additionally we found similar phenotypes in a 
pure endosomal disorder, Dent disease, where the loss-of-function of Clcn5 results in a severe 
endocytic defect concomitant with an accumulation of IFT20 and an increase of the primary cilia 
length. Therefore dysfunctional endosomal—lysosomal pathways due to congenital (Dent disease 
or cystinosis) or acquired (light chain disease) disorders might have similar functional 
consequences on epithelial phenotype, emphasizing the fundamental role of primary cilia as a 
signaling hub to ensure cellular function and homeostasis.  
Autosomal dominant polycystic kidney disease (ADPKD) is the most common inherited 
kidney disease, affecting about 1:1,000 individuals, characterized by the development of cysts 
resulting in the progressive enlargement of the kidneys and, ultimately, leading to end-stage renal 
disease (Ong et al, 2015). ADPKD is caused by mutations in PKD1 or PKD2 which encode 
proteins polycystin-1 and polycystin-2 forming a complex located on the primary cilium which 
allow the transduction of a flow-dependent Ca
2+
 signaling in kidney epithelial cells (Ong, 2017). 
The disruption of this complex impairs the balance of different cellular mechanisms, with 
enhanced proliferation, abnormal fluid secretion and defective PCP driving the cysts progression. 
Recent studies showed an association of proximal tubule markers including β2-microglobulin 
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with GFR decline in patients with ADPKD (Messchendorp, Meijer et al. 2018). Consistent with 
these results, our findings were confirmed in a cohort of ADPKD patients exhibiting a loss of 
LMWPs associated with an increase of ciliary length at an early stage of the disease with a 
normal eGFR; supporting the potential use of PT urinary biomarkers to monitor the rate of 
disease progression in ADPKD 
In summary, this study evidence for the first time PT defects involving an impairment of 
the primary cilium in a PKD context before any renal failure. Our findings support a crucial role 
of primary cilia for PT function and raise several open questions. Indeed, while we demonstrated 
a direct relation between cilia integrity and PT endocytosis, the precise molecular mechanisms by 
which the primary cilium controls the bioavailability of megalin remain unclear. A recent study 
showed that LDL receptor-related protein 1 (LRP-1), which mediates ligands uptake in 
chondrocytes, is concentrated at the base of the cilium and that alterations of the primary cilium 
disrupts LRP-1 organization and impairs LRP-1 mediated endocytosis (Coveney, Collins et al. 
2018). Consistent with our findings, these studies suggest a fundamental role of the cilium in 
regulating the distribution of endocytic receptors at the plasma membrane. However, additional 
mechanisms could be involved as other studies hypothesized that fluid shear stress induces 
cytoskeletal changes that increases the clathrin-coated invaginations size via calcium dependent 
mechanisms (Bhattacharyya, Jean-Alphonse et al. 2017). Additional studies will be crucial to 
decipher the mechanisms governing the regulation of endocytosis by the primary cilium. 
 Few therapeutic solutions are available to target congenital disorders of the 
endolysosomal pathway with the effort focusing mostly on the prevention of complications due to 
the proteinuria and of the development of CKD. We demonstrated for the first time that bone 
marrow (BM) transplantation improves the renal function in a mouse model of Dent disease 
(Gabriel, Belge et al. 2017). Indeed, the Clcn5 knock out mice transplanted with wild-type BM 
showed a significant decrease of LMW proteinuria, glycosuria, calciuria and polyuria up to 4 
months after transplantation. The BM cells differentiated in mononuclear phagocytes (presenting 
features of both dendritic cells and macrophages) and engrafted in the interstitium surrounding 
the PT cells. Although the benefit of BM transplantation has clearly been demonstrated for 
genetic disorders of the hematopoietic system (acute leukemia, sickle cell diseases or SCID), 
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BMT has also been used for enzymes replacement therapy in lysosomal storage disease such as 
Hurler syndrome or cystinosis (Aldenhoven, Jones et al. 2015); (Yeagy, Harrison et al. 2011). 
Our findings showed that the BM-derived mononuclear phagocytes induce a recovery of ClC-5 
and megalin expression, providing a mechanistic basis for the endocytosis rescue. These results 
suggested a cell-to-cell material (mRNA and/or protein) exchange between the engrafted cells 
and the PT cells and prompted us to investigate more closely the interaction between them.  
We developed a coculture system of BM-derived cells and PT cells and we showed that 
the endocytic rescue was prevented when the cells were physically separated by a transwell insert 
system, excluding the hypothesis of a paracrine communication as the mechanism of rescue. 
Another mechanism of intercellular communication is achieved by cell-to-cell contact using 
tunneling nanotubes (TNTs) that are F-actin based structures identified in macrophages and other 
cell types and allowing the transfer of several cargo types including vesicles derived from 
endosomes, lysosomes or cytoplasmic content  (Abounit and Zurzolo 2012, Abounit, Delage et 
al. 2015). TNTs differs from other types of cellular protrusions such as filopodia or dendrites by 
establishing a continuity of the cytoplasm between the connected cells, thus allowing a direct 
transfer of cellular materials (Willnow 2017). We observed similar TNTs in our studies where 
multiple contact points between the transplanted cells and PT cells were identified both in vivo 
and in vitro. We confirmed the crucial role of TNTs by showing that no rescue was observed 
when TNTs formation was prevented with Latrunculin B which altered actin polymerization. 
Interestingly we observed by performing live imaging studies, that the interaction between TNTs 
and PTs cells is highly dynamic, with the BM-derived cells moving on the PT epithelium, rapidly 
establishing contact, exchanging materials and repeating this process in a relatively short time.  
While our studies provide compelling arguments in favor of BMT in Dent disease, the 
underlying regulatory mechanisms remain puzzling. Indeed, we observed a higher engraftment of 
BM-derived cells in Clcn5 knock-out mice but not in wild-type suggesting the existence of an 
unknown “homing” signal released by mutant cells attracting BM-derived cells to their target site 
in the kidney. Additionally BM-derived cells established a closer contact with PT epithelial cells 
through TNTs in Clcn5 knock-out mice than in wild-type. The mechanisms governing the 
formation of TNTs and their guidance to a target cell remain elusive. Finally, additional studies 
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are needed to determine the precise contribution of the transferred material to the correction of 
the endocytic defect. We demonstrated that BM-derived cells provide vesicles containing 
megalin and ClC-5 to the defective PT epithelial cells. However the possibility of RNA exchange 
from the BM-derived cells and the de novo synthesis of functional megalin and ClC-5 in the PT 
cells cannot be excluded.  
 In spite of the open questions, our findings demonstrated the correction of an epithelial 
phenotype in an inherited endosomal disorder and raise the interest for additional studies 
regarding the benefit of bone marrow transplantation in PT disorders. 
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